Effects of polymyxins on the cell envelope of Escherichia coli. by Dixon, R. A
                          
This electronic thesis or dissertation has been





Effects of polymyxins on the cell envelope of Escherichia coli.
General rights
The copyright of this thesis rests with the author, unless otherwise identified in the body of the thesis, and no quotation from it or information
derived from it may be published without proper acknowledgement. It is permitted to use and duplicate this work only for personal and non-
commercial research, study or criticism/review. You must obtain prior written consent from the author for any other use. It is not permitted to
supply the whole or part of this thesis to any other person or to post the same on any website or other online location without the prior written
consent of the author.
Take down policy
Some pages of this thesis may have been removed for copyright restrictions prior to it having been deposited in Explore Bristol Research.
However, if you have discovered material within the thesis that you believe is unlawful e.g. breaches copyright, (either yours or that of a third
party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity, defamation,
libel, then please contact: open-access@bristol.ac.uk and include the following information in your message:
• Your contact details
• Bibliographic details for the item, including a URL
• An outline of the nature of the complaint
On receipt of your message the Open Access team will immediately investigate your claim, make an initial judgement of the validity of the
claim, and withdraw the item in question from public view.
EFFECTS OF POLYMYXINS ON THE CELL ENVELOPE OF 
ESCHERICHIA COLI 
BY 
RONALD ANTHONY DIXON 
A thesis submitted for the degree of 
Doctor of Philosophy 
in the University of Bristol 
BEST COPY 
AVAILABLE 
Variable print quality 
1 
DEDICATION 
This thesis is dedicated to the memory of my father, 
Arthur Dixon (1916-1979) 11 
ii 
MEMORANDUM 
I declare that this thesis represents my own unaided work 
except where otherwise acknowledged. 
The material has never been presented to the University of 
Bristol or any other establishment for the purpose of obtaining 
a higher degree. 
R. A. Dixon 
Department of Microbiology 




I would like to thank my supervisor Dr. Ian Chopra for his 
advice, guidance and constant encouragement during both the 
execution and the reporting of this work. 
I thank Professor A. H. Linton for making laboratory space 
available in the Department of Microbiology; Dr. T. G. B. Howe 
and Dr. A. J. Hedges for helpful discussions and advice; Mrs. 
P. Stirling for her photographic expertise; Mr. R. D. Harber 
for the considerable time and effort spent in introducing me to 
the complexities of microcomputers and the technical staff of 
the Department for support services; Miss F. -Morton for 
performing the experiment described in fig 5.3; Mrs. S. Johnson 
and Mr. K. Hacker for helpful advice and preparing some of the 
electrophoresis samples. I also thank all my colleagues within 
the Department especially Dr. M. Shohayeb, Mr. D. Davies and 
" Miss A. Matranga for helpful discussions. Thanks are due to 
Dr. P. Langford for proof reading this manuscript, any errors 
which remain are mine alone. 
I wish to express my gratitude to Dr. K. R. L. Mansford 
and the management of Beecham Pharmaceutical Research Division 
for providing facilities for work carried out at Brockham Park. 
I thank Dr. J. Heyes and Dr. G. N. Rolinson for their help, 
especially at the inception stage of this project. I would 
particularly like to thank my industrial supervisor Mr. M. J. 
Basker for his help and advice throughout this studentship; Dr. 
M. Wilkinson for his specialist advice and for providing TFM 
iv 
photographs; Mr. J. Warrack for providing SEM photographs; Mr. 
A. Robbins for instruction in the preparation of sarnples for 
EM; Mr. S. Box and Mr. S. Spear for supervising the preparation 
and analysis of PMBN. 
I would also like to thank Dr. M. Dunn and his colleagues 
at Hanvnersmith Hospital, London for introducing me to new 
methods in two-dimensional PAGE. 
Finally thanks are due to my family for their patience and 
consideration throughout the last three years and especially to 
my wife for the preparation of this manuscript and without 
whose support this work would not have been completed (or 
started! ). 
This work was supported by a Science and Engineering Research 
Council CASE Studentship in collaboration with Beecham 
Pharmaceutical Research Division. 
V 
PUBLICATIONS 
Parts of the work presented in this thesis have already been 
published. 
DIXON, R. A. & CHOPRA, I. (1986). Leakage of periplasmic proteins 
from Escherichia coli mediated by polymyxin B nonapeptide. 
Antimicrobial Agents and Chemotherapy 29: 781-788. 
DIXON, R. A. & CHOPRA, I. (1986). Polymyxin B and polymyxin B 
nonapeptide alter cytoplasmic membrane permeability in 
Escherichia coli. Journal of Antimicrobial Chemotherapy 
18: 557-564. 
It is proposed to prepare a third manuscript concerning the 
electron microscopy studies described in Chapter 7. 
vi 
CAT12 












4-dodecyl dimethyl ammonium-l-oxyl 
-2,2,6,6-tetramethyl piperidine 
bromide 




Minimum inhibitory concentration 
Polyacrylamide gel electrophoresis 
Penicillin binding protein 
Sodium dodecyl sulphate 
Scanning electron microscope 







CHAPTER 1 GENERAL INTRODUCTION. 3 
CHAPTER 2 MATERIALS AND METHODS. 23 
Materials 24 
Methods 25 




CHAPTER 4 EFFECTS OF POLYMYXIN B NONAPEPTIDE AND 66 
POLYMYXIN B ON THE CELL ENVELOPE STUDIED 




CHAPTER 5 FURTHER STUDIES OF THE EFFECTS OF 91 
POLYMYXIN B NONAPEPTIDE AND POLYMYXIN B 




CHAPTER 6 ALTERATION OF CYTOPLASMIC MEMBRANE 108 
PERMEABILITY INDUCED BY POLYMYXIN B NONA- 




CHAPTER 7 ULTRASTRUCTURAL CHANGES OF ESCHERICHIA 122 
COLI IN RESPONSE TO POLYMYXIN B NONAPEPTIDE 








The antibiotic polymyxin B acts principally by disruption 
of cellular membranes in Gram-negative bacteria. Its 
deacylated derivative polymyxin B nonapeptide (PMBN) lacks 
antibacterial activity but interacts with the cell envelope and 
demonstrates synergy with a number of antibiotics to which the 
Gram-negative cell is not normally susceptible. In order to 
investigate' the mode of action of PMBN, the studies described 
in this thesis have compared the effects of PMBN and polymyxin 
B on cell envelope structure and function. Both compounds 
affected the integrity of the cell envelope of Escherichia 
coli since they caused release of proteins from cells. The 
origin of the released protein was determined by polyacrylamide 
gel electrophoresis and by using specific enzyme markers. The 
proteins released by both compounds were derived principally 
from the periplasm indicating that the outer membrane must have 
been damaged to allow release. Although polymyxin B and PMBN 
both caused, release of periplasmic proteins, the individual 
proteins released by the compounds differed. Polymyxin B 
caused considerable release of a number of specific 
polypeptides. In contrast PMBN released different individual 
polypeptides. PMBN-treated cells were more susceptible to 
lysis by lysozyme and accumulated the hydrophobic dye crystal 
violet, providing further evidence for the loss of outer 
membrane integrity promoted by PMBN. 
The effects of polymyxin B and PMBN on the permeability of 
the inner membrane of E. coli were also investigated. Both 
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compounds caused loss of free amino acids, uracil and K+ 
from E. coli. The rates of loss promoted by polymyxin B were 
one and a half to two-fold greater than those caused by PMBN. 
Loss of low molecular weight substances by polymyxin B may 
reflect changes in membrane integrity, leading to loss of 
cytoplasmic proteins and subsequent lysis of the cells. 
Although PMBN also induced loss of small molecules from 
E. coli it was not bactericidal. 
Electron microscopy studies showed that polymyxin B and 
PNBN both caused surface damage in E. coli. However, PMBN 
produced less extensive morphological changes in the cell 




The experimental work described in this thesis has been 
concerned with the effects of certain membrane-active 
antibiotics upon the E. coli cell envelope. This general 
introduction provides'a summary of E. coli cell envelope 
structure and function to complement the more specific aspects 
detailed in later chapters. 
1.1 GENERAL FEATURES OF THE CELL ENVELOPE OF GRAM- 
NEGATIVE BACTERIA 
The cell envelope of a Gran-negative cell is a highly complex 
structure and has been the subject of a number of-recent 
reviews (Braun & Hantke, 1974; Costerton et al., '1974; Rogers 
et al., 1980; Lugtenberg & Van`Alphen, 1983; Nikaido, T1985 
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and Nikaido & Vaara, 1985). The cell envelope consists of a 
three tier structure, the cytoplasmic (inner) membrane, the 
peptidoglycan (murein) layer and the outer membrane (see fig 
1.1). The outer membrane, however, is not always the outermost 
layer of the cell envelope as it is often covered with an 
amorphous capsular material consisting of polysaccharide. 
Surface appendages such as flagella, fimbrae and pili are 
anchored in the cell envelope (Depamphilis, 1971), but project 
fron the outer layers of the cell into the surrounding 
environment. 
1.1.1 Cytoplasmic membrane 
The cytoplasmic membrane of Gram-negative bacteria is composed 
r 
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Fig 1.1 The structure of the cell envelope of Gram-negative 
bacteria showing the major molecular components and their 
approximate dimensions. (From Ingraham et al 1983). 
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bilayer structure (Salton & Owen, 1976). Basically the inner 
membrane provides an osmotic barrier for the cell. The 
hydrophobicity conferred by the phospholipids is modified. by 
the presence of a wide variety of polypeptides in the membrane 
which allow access of nutrients. The cell membrane plays a 
crucial role in macromolecular syntheses with virtually all 
metabolic reactions of the cell occurring within or internal to 
the membrane. The major functions of cytoplasmic membrane 
proteins are energy generation, active and facilitated 
transport of nutrients, export of°by-products. and enzymic 
synthesis of cell envelope components. 
1.1.2 Murein (peptidoglycan)-layer 
In Gram-negative bacteria, a monolayer of peptidoglycan 
surrounds the cytoplasmic membrane although it is probably not 
attached covalently to it. The mechanical strength of 
peptidoglycan reflects its unique structure. It consists of a 
network of-linear amino sugar chains containing alternate 
residues of N-acetylglucosamine and N-acetylmuramic, acid. They 
are covalently linked to each other via tetrapeptide residues 
which are attached to the N-acetylmuramic acid (see Schleifer & 
Kandler, 1972 for review). The peptidoglycan layer provides 
Gram-negative cells such as E. coli with rigidity and can in 
addition be partly responsible for the rod shape of the cell. 
The peptidoglycan in the cell is firmly bound to the outer 
membrane by covalent linkage of murein lipoprotein to some of 
the tetrapeptide residues of the peptidoglycan. This 
attachment is reinforced. by non-covalent bonding between the 
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peptidoglycan and other proteins of the outer membrane. 
1.1.3 Outer membrane 
The outer membrane of Gram-negative bacteria forms the barrier 
between the external environment and the cell. It plays a role 
in receptor-mediated interactions with other cells, phages and 
colicins. In addition the outer membrane participates in 
conjugation between bacteria and adhesion receptors of certain 
bacteria to their marnnalian host. (Curtiss, 1981; Gaastra & De 
Graaf, 1982; Chopra & Linton, 1986 and Chopra, 1986). 
The outer membrane contains, in addition to phospholipids 
and proteins, lipopolysaccharide (LPS) as a major constituent. 
The current model for its organisation is shown in fig 1.2 
(Nikaido & Vaara, 1985). Structurally the membrane is composed 
of a bilayer of two opposed lipid leaflets. The inner leaflet.. 
contains phospholipid molecules identical to those found in the 
cytoplasmic membrane. However, phospholipid in the outer 
leaflet appears to be largely replaced by LPS -a molecule 
unique to the outer membrane of Gram-negative cells. Thus, the 
membrane exhibits unusual asymmetry. The LPS carries a net 
negative charge resulting in a strong negative surface charge 
on Gram-negative cells. The presence of LPS in the outer 
membrane plays an important role in the impermeability of the 
outer membrane to hydrophobic compounds (Nikaido, 1976). 
Recent X-ray diffraction studies (Labischinski et al., 1985) 
have demonstrated a high state of order in isolated LPS, which 
may possibly account for its function as a permeability barrier 
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Fig 1.2 Schematic diagram of the outer membrane of E. coli. 
(From Nikaido & Vaara 1985). 
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membrane bilayer are stabilized in part by the presence of 
divalent cations (see later). The outer membrane is almost 
devoid of enzymatic activity, only a phospholipase and a 
protease are known to be located there (Vaara & Viljanen 1983). 
1.1.4 Periplasmic region 
The region between outer and inner membranes is only partially 
occupied by peptidoglycan. This area is known as the periplasm 
(previously the periplasmic space) and contains at least 30-50 
species of protein comprising 4% of the total-cellular protein. 
Proteins can be classified into three groups according to their 
function: 
a), catabolic enzymes (e. g. alkaline phosphatase etc. ) which 
degrade solutes into a form that is suitable for transport 
through the cytoplasmic membrane. 
b) binding proteins (e. g. maltose, glutamine etc. ) which have 
high affinities for nutrients such as amino acids and sugars. 
c) degradative enzymes (e. g. beta-lactamase etc. ) which degrade 
molecules such as antibiotics-that are harmful to the,., cell. 
Periplasmic proteins are normally retained within the cell 
unless the outer membrane has been damaged in some way, (see 
later). At intervals, the outer membrane appears to be-. in' 
contact with the cytoplasmic membrane via areas known as 
'zones 
of adhesion'. These zones, which bypass the periplasm have 
been implicated in the translocation of newly synthesised LPS 
and outer membrane proteins from the cytoplasmic membrane to 
the outer membrane-(Lugtenberg &-Van Alphen, 1983). 
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1.2 INDIVIDUAL CONSTITUENTS OF THE OUTER MEMBRANE 
1.2.1 Phospholipids 
All°phospholipids of E. coli are located in the cell envelope. 
Phosphatidylethanolamine is the major species although 
substantial amounts of phosphatidylglyerol and diphospha- 
tidylglyerol (cardiolipin) are found (fig 1.3). The fatty acid 
moieties are designated R1 and R2 in the figure. 
Their structures are shown in fig 1.4. The phospholipid 
composition of the outer membrane is usually very similar to 
that of the cytoplasmic membrane. Several authors e. g. Osborn 
et al., (1972) and Lugtenberg & Peters, (1976) have reported 
that compared with the inner membrane, the outer membrane of 
E. coli is enriched for phosphatidylethanolamine but contains 
less of the. two other phospholipid types. The abundance of 
phosphatidylethanolamine, which may represent as much as 90$ of 
the outer membrane phospholipid, is consistent with its ability 
to form stable bilayers with LPS (see above). Lugtenberg & 
Peters, (1976) have shown that when present in the outer 
membrane this species of phospholipid consistently contains 
more saturated fatty acids than phosphatidylethanolamine in 
the cytoplasmic membrane. This probably explains why the 
E. coli outer membrane is enriched for saturated fatty acids 
(Lugtenberg & Peters, 1976). - 
1.2.2 Lipopolysaccharide (LPS) 
The structure and function of LPS have been extensively 
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Fig 1.3 Structure of bacterial phospholipids from E. coli. 
R1 and R2 = Fatty acyl residues. 
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Galanos et al., (1977) and Luderitz et al., (1982). The 
structure of E. coli LPS is shown in fig 1.5. It is an 
unusual lipidic molecule having a hydrophobic region which 
contains lipid A. This comprises the lipid moiety of LPS in 
the outer leaflet. Lipid A is a glycolipid consisting of a 
glucosamine disaccharide backbone which carries at least two 
phosphate residues and six or seven fatty acid chains. LPS 
appears to be anchored in the outer membrane by binding to 
outer membrane proteins and by non-covalent cross-bridging of 
adjacent LPS molecules with divalent cations (Leive et al., 
1968 and DePamphilis, 1971). The polysaccharide portion of LPS 
("R core") tends to be well conserved amongst Gram-negative 
bacteria and contains the unique sugars, ketodeoxyoctonate 
(3-deoxy-D-manno-octulosonic acid) (KDQ) and L-glycero-D- 
mannoheptose, both of which are LPS specific. In addition, it 
contains phosphate, ethanolamine phosphate, and ethanolamine 
pyrophosphate. Numerous mutants with defects in core structure 
have been isolated by selection for-resistance towards the 
polymyxins (Vaara et al., 1979). The peripheral part of the 
core polysaccharide with its attached, often branched, "0" 
polysaccharide side chains projects outwards and unlike the 'R' 
core shows a great evolutionary divergence. The structure of 
the subunits of the "0" antigen shows extreme diversity even 
within a single genus like Escherichia or Salmonella 
(Orskov et al., 1977). This property is used in serotyping 
to identify say, substrains of one species in great detail. 
Colonies of strains with or without the "0" antigen often have 
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Name (length) Structure 
Major species 
Palmitic (16: 0) CH, (CH2)14000H 
HH 
Palmitoleic (16: 1) CHa(CH2)5C=C(CH07000H 
HH 
cis-Vaccenic (18: 1) CH3(CH2). iC-C(CH2)4000H 
Minor species 
Lauric (12: 0) CH3(CH2)m000H 
Myristic (14: 0) CH:, (CH2)12000H 
CH2 
c4s-9,10-Methylene-hexade- CH3(CH1)fC-C(CH2)7000H 
canoic (17: 0) 
HH 
Stearic (18: 0) CH3(CH2)1,; 000H 
CHF 
I 
Lactobacillic (19: 0) CH: º(CH2)fC C(CH2)HCOOH 
HH 
Unique to lipopolysaccharide 
OH 
3-D-H droxym y yristic (14: 0) CH3(CH2), (, CH-CHj-000H 
Fig 1.4 Structures of common fatty acids in bacteria (From 
Ingraham et al 1983). 
Fig 1.5 Generalised structure of bacterial 
lipopolysaccharide. 'O" side chains and outer core 
composition vary considerably (From Hammond et al 
1984). In E. coli K12 strains the '0' antigen is 



























a (S)mooth or (R)ough appearance. Analysis of the core 
structure of the K12 strain of E. coli, used in numerous 
laboratories and throughout this study, has indicated that it 
lacks the "0" antigen and is therefore classified as an 'R' 
strain (Prehm et al., 1976). 
1.2.3 Proteins 
The proteins associated with the outer membrane have been 
intensively studied over the past ten years. Excellent reviews 
include those by Nikaido & Nakae, (1979); Osborn & Wu, (1980) 
and Lugtenberg & Van Alphen, (1983). There are twenty to 
thirty different species of proteins in the outer membrane of 
Gram-negative cells. Certain of these proteins play a role in 
the stabilization of the structure and securing the outer 
membrane to the peptidoglycan layer. In addition, some 
proteins facilitate the permeation of nutrients and therefore 
influence the permeability properties of the outer membrane 
(Rogers et al., 1980 and Nikaido, 1985). 
a) Murein lipoprotein 
Lipoprotein is involved in stabilizing the outer membrane and 
anchoring it to the underlying peptidoglycan. It is the most 
abundant outer membrane protein but is only a small polypeptide 
of molecular weight 7,200. It is covalently bound to the 
diaminopimelic acid residue of peptidoglycan, although the 
majority of copies of the protein exist in the cell envelope in . 
a free (non-attached) form. The isolation of IPP mutants 
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lacking the gene for both forms of lipoprotein show that it is 
not essential for the survival of the cell. However, such 
mutants have severe defects including increased sensitivity to 
ethylenediaminetetraacetic acid (EDTA) and leakage of 
periplasmic proteins, which suggests a role for lipoprotein in 
the stabilization of the outer membrane. 
Other outer membrane proteins also have important 
structural functions. For example OmpA plays an essential-role 
in maintaining cell envelope integrity (see Chapter 5). 
b) Diffusion pore proteins (peptidoglycan-associated) s 
In E. coli 80% of the outer membrane protein content is made 
up of five different major species (Hall & Silhavy, 1981). 
Nikaido & Nakae, (1979) have proposed a concept of water filled 
channels or pores in order to explain how nutrients and solutes 
of'molecular weight 600 or less pass through the outer 
membrane. The pores (or porins) of Gram-negative bacteria are 
-trimeric aggregates which are in many-cases tightly associated 
with the peptidoglycan layer. Since they'also act as receptors 
for bacteriophages and bacteriocins, the porins must be exposed 
at'the surface as well as opening to the periplasm and` 
therefore completely span the membrane., E. coli K12 contains 
two major peptidoglycan-associated proteins known as OmpF and 
OmpC (molecular weight 36.5 and 37K) which have been identified 
as porins and act as general diffusion pathways for the cell. 
They are immunologically related to each other (Overbeeke et 
al., 1980 and Smyth, 1985) and share a similar amino acid 
composition'-and N-terminal sequence (Ichihara & Mizushima, 
1978). In addition, approximately 10-20 different species of 
17 
minor proteins have been identified. Some of these proteins 
are implicated in iron transport, vitamin B12 uptake or 
nucleoside transport. However, in most cases the roles of the 
minor proteins are unknown. 
1.3 THE OUTER MEMBRANE AS A PERMEABILITY BARRIER 
Gram-negative bacteria have an exceptionally efficient barrier 
against the external environment. The outer membrane by the 
combination of negative charge and divalent cation cross- 
bridging of LPS is responsible for the exclusion of a large- 
number of molecules. The presence of the outer membrane 
ensures that Gram-negative bacteria are resistant to host 
defence factors such as lysozyme. This enzyme is present in 
certain body fluids e. g. serum and tears and appears to have 
unrestricted access to the peptidoglycan of Gram-positive 
cells, causing them to'lyse., The outer membrane of Gram- 
negative bacteria, however, prevents lysozyme fron gaining 
access to the underlying peptidoglycan and cell lysis fails-to, 
occur. More generally, the outer-membrane of Gram-negative 
bacteria is an effective barrier against bile and digestive 
enzymes for organisms which normally inhabit the mammalian gut 
(Nikaido & Nakae,, 1979). The presence of the barrier is also 
responsible, in part, for the general-lack of susceptibility of 
Gram-negative bacteria to antibiotics. 
The failure of certain antibiotics which are effective 
against Gram-positive organisms may, however, be ascribed to 
the inability of the agents to penetrate the Gram-negative 
I 
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outer membrane (Nikaido, 1976). The cell is able to exclude 
therefore, many antibiotics such as erythromycin, lincomycin, 
clindamycin, novobiocin, fusidic acid, nafcillin and 
cloxacillin (Nikaido & Nakae, 1979). Furthermore, the outer 
membrane of the cell reduces significantly the penetration of 
benzyl penicillin, ampicillin, carbenicillin and most of the 
first and second generation cephalosporins (Nikaido & Nakae, 
1979; Richmond & Wötton, 1976; Zimmerman & Rosselet, 1977 and 
Curtis et al., 1979a & b). Thus, the barrier property of the 
outer membrane excludes a number of clinically useful 
antibiotics that might otherwise be used to treat infections 
caused by Gram-negative organisms. This suggests that should 
the permeability of the outer membrane be disorganised, then 
bacteria would become sensitive to an extended range of 
antibiotics (Vaara & Vaara, 1983a). 
1.4 AGENTS ACTIVE AGAINST CELL MEMBRANES 
i 
As already noted this thesis has. been concerned-with the action 
of membrane-active agents and particularly the polymyxins. The 
polymyxins (fig 1.6) are produced by Bacillus polymyxa and 
they exert antibacterial activity predominantly against 
Gram-negative organisms. The 'natural' antibiotics and 
semi-synthetic analogues have molecular weights ranging from 
1000 to 1200. Characteristically, they are all polycationic 
decapeptide antibiotics with a fatty acyl 'tail' and five 
positively charged groups (fig 1.6). The polar head and 








Polymyxin A McOct D-DAB D-LEU L-THR 
Polymyxin BI McOct L-DAB D-PHE L-LEU 
Polymyxin B2 MeHep L-DAB D-PHE L-LEU 
Polymyxin D1 McOct D-SER [)-LEU t. -THR 
Polymyxin D2 MeHep D-SER D-LEU L-THR 
Polymyxin E1 McOct L-DAB D-LEU , 
L-LEU 
(Colistin A) 
Polymyxin E2 MeHep L-DAB D-LEU L-LEU 
Circulin A McOct L-DAB D-LEU L-ILEU 
Octopeptin B1 ßOHMeDec - D-LEU L-LEU 
Octapeptin A2 ßOHMeNon - D-LEU L-LEU 
Octapeptin A3 ßOHDec - D-LEU L-LEU 
Octapeptin B1 ßOHMeDec - D-LEU L-PHE 
Octapeptin B2 ßOHMeNon - D-LEU L-PHE 
Octapeptin B3 ßOHDec - D-LEU L-PHE 
Octapeptin Cl ßOHMeOct - D-PHE L-LEU 
DAB = Diaminobutyric acid MeOct = 6-Methyloctanoic acid 
MeHep = 6-Methylheptanoic acid MeDec = 8-Methyldecanoic acid 
MeNon = 8-Methylnonanoic acid Dec = n-decanoic acid 
° Octapeptins-omit dipeptide in square brackets. 
Fig 1.6 Composition of some polymyxins and octapeptins (From 
Gale et al 19$1). 
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permit the polymyxins to interact with both LPS and 
phospholipids (Hsu-Chen & Feingold, 1973). 
The ultimate lethal target of polymyxins is generally 
thought to be the cytoplasmic membrane to which polymyxin binds 
(Teuber & Bader, 1976). This conclusion was also reached by 
Newton (1956), when he originally studied the binding of 
polymyxin B to cells using a fluorescent polymyxin derivative. 
He found that following fractionation of cells fluorescent 
activity was located exclusively in the cytoplasmic membrane. 
In this location the antibiotic rapidly destroys the barrier 
property of the cytoplasmic membrane, causing leakage of cyto- 
plasmic components and ultimately cell death (Teuber, 1974; 
Storm et al., 1977). However, for this lethal event to take 
place polymyxin B must first traverse the outer membrane. 
barrier. Polymyx ins are too large to enter the cells through 
the porin channels (see above) of*Gräm-negative bacteria 
(Nikaido & Vaara, 1985). They therefore gain access by dis- 
rupting or disorganising the outer membrane (storn et al., 
1977). To do this polymyxin B binds to the outer membrane 
causing alterations visible by electron microscopy (Schindler & 
Teuber, 1975; Lounatmaa et al., 1976; and Gilleland & Murray, 
1976) and which reflect structural disorganisation of the 
membrane: Initial binding to the outer membrane appears to 
involve an interaction-of polymyxin B with the LPS (possibly 
involving the phosphate groups) (Morrison & Jacobs, 1976; 
Schindler & Osborn, 1979 and Vaara'et al., '1979). In 
addition polymyxin B is known to interact with divalent cation 
binding sites on LPS (Schindler & Osborn, 1979) causing 
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displacement of ions by competition rather than chelation. 
Disturbances in outer membrane stability resulting from such 
interactions could account for the changes in permeability 
induced by polymyxin B. The enhancement of permeability can be 
reversed however by excess magnesium ions, indicating that 
divalent cation sites are involved in the mode of action of 
polymyxin B (Cerny & Teuber, 1972 and Newton, 1956). 
EDTA is another agent which disorganises the outer- 
membrane of cells and increases permeability. It exhibits 
strong binding affinity for metal ions such as magnesium. In 
the presence of Tris(hydroxymethyl)aminomethane (Tris), 
treatment with EDTA chelates magnesium ions from the outer. 
'membrane resulting in the release of specific components such 
as LPS. This. results irr a general enhancement of permeability 
to a number of agents including lysozyme (Leive, 1974). The 
effects of polymyxin B on, the outer membrane differ from EDTA 
in.. that the former apparently fails to release LPS into the 
medium (Vaara & Vaara,. 1983b). It has been proposed (Nikaido & 
Vaara, 1985) that EDTA may act by removing LPS and creating 
phospholipid bilayer regions in the outer membrane.., -A 
significant difference between the two agents is that polymyxin 
B-treated cells release substantial levels of periplasmic 
proteins (Cerny & Teuber, 1972) whereas EDTA releases only very 
small amounts of these proteins. 
Other polycationic agents such as protamine and polylysine 
appear to be more like EDTA with respect to their effects on 
the outer membrane. They render the outer membrane permeable 
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to several hydrophobic agents (Katsu et al., 1984a) and bind 
LPS which is considered to trigger disruption of the 
permeability barrier (Katsu et al., 1984b). The basic 
polypeptides (protamine and polylysine) induce substantial LPS 
release but cause no leakage of periplasmic proteins or visible 
structural damage to the cell (Vaara & Vaara, 1983b). These 
workers have also reported that a variety of cations can bind 
isolated LPS but do not disrupt the barrier function of cells. 
Therefore, the relationship between peptide structure and 
permeability increases remains obscure at present. 
Unfortunately, both the polymyxins and EDTA are toxic-to 
eukaryotic cells and their usefulness as therapeutic agents is 
limited (Storm et al., 1977). Successful attempts by Chihara 
et al., (1973,1974) to reduce the toxicity of polymyxin E 
(colistin) towards eukaryotic cells by the removal of the fatty 
acid tail resulted in the concomitant loss of antibacterial 
activity in the modified product (colistin nonapeptide). These 
results prompted a similar approach by Vaara & Vaara, (1983a & 
b) to produce a non-toxic derivative, polymyxin nonapeptide 
(PMBN), from polymyxin B. PMBN has little or no antibacterial 
activity but appears to retain the ability of the parent 
peptide to disorganise the outer membrane. 
Certain aspects of the mode of action of polymyxins are 
unknown and the results described in this thesis present an 
extension of our knowledge concerning their action. 
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CHAPTER 2 
MATERIALS AND METHODS 
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2.1 CHEMICAL REAGENTS 
The majority of chemicals were purchased either from BDH 
Laboratory Chemicals Ltd., or the sigma Chemical Co. both 
located in Poole, Dorset. Polymyxin B Sulphate was purchased 
from the Calmic Medical Division, Wellcome Foundation Ltd., 
London and nitrocefin was a gift from Beecham Pharmaceuticals 
Research Division, Brockham Park, Surrey.: 3H labelled 
L-amino acid mixture (code TRK. 440), 6-[3H]-ur'acil (code 
TRK. 240) and L-[35S)-methionine (code SJ. 204) were 
purchased from Amersham International Plc., Amersham, 
Buckinghamshire. 
2.2 BACTERIA 
E. coli K12 3300 pBR322 which produces beta-galactosidase 
constitutively was used primarily in these studies. The strain 
was constructed by transformation (Humphreys et al., 1975) of 
strain 3300 lacl-, lac0+, lacZ+, lacY+ (Luria et 
al., 1960) with plasmid'pBR322, which encodes resistance to 
beta-lactams and tetracycline (Bukhari et al., 1977 and 
Köpylova-Sviridova et al., 1975). Bacteria lacking this 
plasmid were used for penicillin binding proteins (PBPs) 
studies. Cultures Were maintained on nutrient agar or Dorset's 
egg slants, in the dark at room temperature or 40C. The 
E. coli mini cell-producing strain DS410 (Hallewell & 
Sherratt, 1976) containing pBR322 was also used. 
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2.3 MINIMUM INHIBITORY ANTIBIOTIC CONCENTRATION 
DETERMINATIONS 
Antibiotics were dissolved in sterile distilled water. Minimum 
inhibitory concentration (MIC) values were determined by serial 
dilution into nutrient agar (Lab M. Agar, London Analytical 
Company, Bury, Lancs. ). The surface of the dried agar was 
inoculated with 0.07ml from an undiluted overnight nutrient 
broth culture (Lab M), using a replicating device to deliver 
approximately 106 colony forming units (cfu). The MIC 
value was determined after 18h incubation at 370C and 
defined as the lowest concentration ofýantibiotic to prevent or 
greatly diminish, visible growth. 
2.4 MINIMUM BACTERICIDAL ANTIBIOTIC CONCENTRATION 
DETERMINATIONS 
Antibiotics were serially diluted into nutrient broth which was 
inoculated with 0.02ml of an; overnight broth culture of 
E. coli to'yield an. inoculum of; approximately 106 cfu/ml. 
A 10m1 volume was withdrawn from each tube after 18h incubation 
at 370C and subcultured onto antibiotic-free nutrient 
agar. The MBC value was determined as the lowest concentration 
of antibiotic to prevent visible growth after overnight 
incubation at 370c. -- 
2.5 CHECKERBOARD TECHNIQUES TO ASSESS ANTIBACTERIAL 
COMBINATIONS 
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Fusidic acid and benzyl penicillin MIC's were determined with 
liquid cultures using a checkerboard technique (Krogstad & 
Moellering, 1980) in ILinbro" multidishes (Flow Laboratories, 
Irvine, Scotland. ). Combinations of antibiotics were tested by 
the addition of 0. lml of appropriately diluted fusidic acid or 
benzyl penicillin and O. lml of diluted PMBN. Each well was 
inoculated with exponentially growing cells of E. coli in 
1.8ml of nutrient broth (106cfu/ml). Thus, individual 
wells contained a unique combination of each antibiotic tested 
and PMBN. Multidishes were incubated at 370C overnight -, 
and growth recorded as turbidity. 
2.6 DETERMINATION OF VIABLE NUMBERS OF BACTERIA FOLLOWING 
EXPOSURE M POLYMYXINS 
E. coli K12 3300 (pBR322) cells were grown in nutrient. broth 
(LabM) to mid-exponential phase and the cells harvested by. 
centrifugation at 8K/10 min/40C. The cells were washed 
twice in 10mM sodium. phosphate buffer pH 7.4 and resuspended in 
the same buffer to give a range of cell densities from 1010 
to 106cfu/ml. Aliquots of each suspension were treated at 
time zero with either polymyxin B (200ug/ml), PMBN (200ug/ml) -- 
or remained untreated and were-gently agitated at 370C in 
a waterbath. Samples, were removed at-timed intervals, rapidly 
diluted in nutrient broth and plated onto nutrient agar to - 
determine, viable bacteria according, to the method of Miles et 
al. (1938). It was necessary to dilute cultures containing 
high concentrations of polymyxin B by at least 1/104, to 
obviate the "carry-over" effects of: the antibiotic. 
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2.7 PREPARATION OF PMBN AND ITS CHARACTERIZATION 
The proteolytic enzyme ficin was used to prepare PMBN from 
polymyxin B as described by Chihara et al., (1973,1974). 
Polymyxin B (2g) was dissolved in 10mM sodium phosphate buffer 
(pH 7) and mixed with an equal volume of the same buffer 
containing 1.5g of ficin (Sigma Chemical Co. ). The mixture was 
incubated overnight at 370C with shaking. Ficin residue 
was destroyed by boiling for 5 min and removed by 
centrifugation (3K/10 min). The resulting supernatant was 
subjected to solvent extractions in both acidic and alkaline 
conditions. The supernatant was adjusted to pH 2 with 
concentrated hydrochloric acid, mixed in a separating funnel 
and 0.5 x volume n-butanol added. Following three extractions, 
the aqueous layer was adjusted to pH 8 with. NaOH and alkali 
extraction performed three times with n-butanol. Finally the 
aqueous phase was neutralised by the addition of 1M HCl and 
layered onto an ion exchange column consisting of Amberlite 
resin IRA 410 (BDH). The aqueous phase was collected, frozen 
and freeze-dried for 8-12h. PMBN prepared by this method was 
characterised by thin layer chromatography (TLC), high-pressure 
liquid chromotography (HPLC), nuclear magnetic resonance (NMR) 
and spectral analysis. TLC=was carried out as previously 
described (Vaara & Vaara, 1983a). Prepared TLC sheets (Eastman 
Chromatogram=cellulose sheets=13255, Kodak) were spotted and 
run for 4h in butanol/acetic acid/water (60/20/20). The plates 
were developed with ninhydrin solution and the-results, 
recorded. A small sample of the freeze-dried material was used 
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for HPLC analysis. HPLC was performed on a Waters u Bondapak 
C18 (P/N 84042 S/N) column [30cm x 3.9mm (internal diameter)] 
eluted with methanol - 0.1M phosphate buffer (pH 3) (1.5 : 8.5, 
v/v) at 3.0ml/min. The chromatographic equipment consisted of 
a Waters model 6000A pump, Rheodyne injector fitted with a 20u1 
loop and a variable-wavelength UV detector set at 210 nm for 
detection of polymyxin and PMBN (Bird et al., 1984). The 
retention time for 20u1 of each solution was measured. . 
Spectral analysis of the compounds was performed with a Pye 
Unicam PU8800 spectrophotometer linked to an"Acorn 
microcomputer loaded with Pye Unicam scanning software. Each 
compound was prepared at 10mg/ml of distilled water and tested 
in 1cm cuvettes. 
. 
11 2.8 ENZYME PROTEIN, AND 3-KETODEOXYOCTONATE ASSAYS 
2.8.1 Beta-lactamase 
Beta-lactamase (EC 3.5.2.6) was assayed using the chromogenic 
cephalosporin nitrocefin (0"Callaghan et al., 1972). Samples 
(50u1) containing amounts of beta lactamase were diluted in 
0.95m1 of 10mM sodium phosphate buffer (pH-7) and placed in 3ml 
cuvettes maintained at 370C in a cell preheater- 
(Pye-Unicam Ltd-, Cambridge). Cuvettes were transferred to a 
temperature controlled cell holder in a PU8800 spectro- 
photometer (Pye-Unicam Ltd. ) and 2ml of nitrocefin (50ug/ml) 
added. The change in absorbance at 482nm/min was recorded and 
the amount of'substrate destroyed was calculated by applying 
the formula below: 
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umoles nitrocefin destroyed = 
/min/ml of enzyme 
Abs482 /min. 
-- --------- xVx0.3 
where "V" = conversion to lml 1.59 
2.8.2 Beta-galactosidase 
Beta-galactosidase (EC 3.2.1.23. ) was assayed by its ability to 
liberate o-nitrophenol (ONP) from o-nitrophenyl-B-D- 
galactopyranoside "(ONPG) (Chopra et al., 1977). To assay for 
beta-galactosidase in the experimental samples, 50ul was taken, 
diluted with 0.95ml of 10mM sodium phosphate buffer (pH 7.4) 
and pre-incubated for a few minutes at 370C. A freshly 
prepared solution of ONPG (4m1) in 10mM sodium phosphate buffer 
(pH 7.4) was added to the sample and incubated-at 370C 
until the yellow colour of ONP developed (approximately 15-30 
min). The reaction was stopped by the`addition of 5ml of a 
0.5M solution of sodium carbonate. - The absorbance of the 
solution was measured against a reagent blank at 420nm; in a 
spectrophotometer: The amount of ONP liberated from ONPG was 
assessed by reference to a standard curve of ONP concentrations 
(range 0.1-2 umoles) prepared in appropriate volumes of 10mM 
sodium phosphate buffer (pH 7.4) against absorbance at 420nm. 
2.8.3 3-Ketodeoxyoctonate 
3-ketodeoxyoctonate (KDO) was measured by the method of 
Karkhanis et al., (1978). "50u1 aliquots containing unknown 
amounts of KDO were diluted in 0.45m1 of 10mM sodium phosphate 
(pH 7.4) and placed in Eppendorf centrifuge tubes. To each 
30 
tube 0.5m1 of 0.4N sulphuric acid was added and the samples 
heated at 1000C in a waterbath for 30 min to release KDO. 
The tubes were spun in a microfuge (3 min) and O. 5ml of the 
supernatant removed into bijoux bottles. The mixture was then 
treated with 0.25ml of a solution of 0.04M periodic acid in 
0.125N sulphuric acid, left at room temperature for 20 min and 
then 0.25ml of a 2.6% solution of sodium arsenite in 0.5N 
hydrochloric acid was added. Finally, the addition of 0.5m1 of 
a 0.6% solution of thiobarbitic acid produced a red 
chromophore. The tubes were heated at 100C for 15 min 
0 
and the chromophore extracted, whilst hot, with iml dimethyl- 
sulphoxide (DMSO). The absorbance of the samples was read at 
548nm against the reagent blank. A set of standard KDO 
solutions ranging in concentration from 10-50ug KDO per tube 
were prepared and subjected to the above procedure. The-amount 
of KDO in the material was calculated fron the standard curve. 
Standard lines were drawn for beta-galactosidase and 
keto-deoxyoctonate calibrätions-using a computer program 
(chopra, 1985b) for regression analysis. The coefficient of 
correlation was calculated for each line and those lines 
displaying poor correlation rejected. 
2.8.4 Proteins 
Protein was assayed according to the method of'Bradman (1976) 
using a . Protein Assay Kit' (Bio-Rad Laboratories Ltd., 
Watford). The assay is based on the colour change of a dye in 
response to various concentrations of proteins. Initially a 
protein standard curve was constructed by dilution of bovine 
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serum albumin in 10mM sodium phosphate buffer (pH 7.4) to give 
a range of concentrations from 10-140ug-per tube. Dye reagent 
concentrate was diluted and filtered according to the 
manufacturers instructions and 5m1 added to each tube 
containing 100ul of each of the standard protein 
concentrations. After 5 min, the absorbance of the solutions 
was read at 595nm with a spectrophotometer. (The colour is 
stable between 5-60 min). Plots of absorbance (595nm) versus 
protein concentration (ug) were drawn using a computer program 
for regression analysis (Chopra, 1985b). The coefficient of 
correlation was calculated as before and those lines displaying 
poor correlation rejected. Experimental samples (100ul) were 
treated as above; -5ml of dye reagent added and absorbance 
readings at 595nm recorded. The amounts of protein in 
each 
sample were estimated from standard curves with. correlation 
coefficients >0.99. 
2.9 PREPARATION OF BACTERIAL CELL FRACTIONS. 
2.9.1 Separation of inner and outer membranes. 
Inner (cytoplasmic) and outer membranes of E. coli'K12 3300 
(pBR322) were separated either by Sarkosyl treatment to >> 
solubilise the inner membrane (Filip et al., 1973 and Chopra 
& Shales, 1980) or by using a sucrose density gradient method 
(yamato et al., 1975). To prepare envelopes for Sarkosyl 
treatment, cells in the early logarithmic phase of growth were 
harvested at 6K/5 min/40C washed in 10mM sodium phosphate 




Following disruption by sonication (4 x 20 sec with-30 sec 
cooling periods), unbroken cells were removed by low speed 
centrifugation (3K/30 min/40C) and crude envelopes 
isolated from the supernatant by high speed centrifugation 
(40K/60 min/40C). Cell envelopes were resuspended in 
0.5%(v/v) Sarkosyl (N-lauroyl sarkosine-sodium salt) (Filip 
et al., 1973). Sarkosyl insoluble fractions containing 
outer membrane proteins were isolated by centrifugation 
(40K/2h/40C), washed with buffer and stored at -200C. 
Proteins in the Sarkosyl-soluble fraction were precipitated 
with cold acetone, collected by centrifugation, dried at room 
teirperature overnight and stored at -200C. Separation of 
inner and outer membranes on sucrose gradients (Yamato et 
al., 1975) was achieved from cells in which periplasmic and 
cytoplasmic fractions had. been removed (see below). Crude 
envelopes were suspended in. 40ml of 3mM EDTA (pH 7.2) and 
centrifuged at 40K/60 min/40C. The envelopes were washed, 
resuspended in 8m1 of 3mM EDTA (pH 7.2) and layered over a, 
cushion of 3mM EDTA containing 52% (w/v). sucrose. The s 
envelopes were centrifuged at 40K/12-18h/40C and the upper 
band containing inner membrane was removed. To remove 
contaminating whole cells from the outer membrane preparation, 
the pellet was resuspended in 3mM EDTA containing 10% (w/v) 
sucrose-and layered on to a sucrose step gradient. constructed 
from 64% (w/v) sucrose (6m1) and 9ml of 70% (w/v) in 3mM EDTA. 
The gradients were spun to equilibrium (40K/24-48h/40C). 
The material containing outer membrane proteins was located at 
the interface of the 64-70% layers and contaminating whole 
I 
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cells were pelleted. 
2.10 ISOLATION OF PERIPLASMIC AND CYTOPLASMIC FRACTIONS 
The procedure of Yamato et al., (1975) was followed to 
isolate proteins from the periplasm and cytoplasm. Bacteria 
were grown to the early logarithmic stage of growth in nutrient 
broth and harvested. Cells were cooled to 40C,. washed and 
resuspended in 16m1 of 30mM Tris-HC1 (pH 8) containing 20% 
(w/v) sucrose (TS 20) to give approximately 1011 bacteria 
per ml. The cells were treated with solutions of, 7mg/ml 
lysozyme in TS20 (0.176m1) and 0.1M EDTA in TS20 (1.6ml). The 
solutions were added rapidly and simultaneously to cells 
maintained on ice, gently mixed and left on ice for a further 
20-30 min. The spheroplasts were collected by centrifugation 
at 8K/30 min/40C and the supernatant containing. 
periplasmic proteins and lysozyme was subjected to dialysis 
overnight at 40C against deionised water and freeze-dried. 
Spheroplasts were resuspended, in 16m1 of 3mM EDTA pH 7.2 
containing 20% (w/v) sucrose (ES20) and sonicated for 6x 20. 
sec bursts with 30 sec cooling intervals, diluted in 3mM EDTA 
(pH 7.2) and spun at 40K/1.5h/40C. The supernatant 
containing the cytoplasmic fraction of the cell was removed, 
dialysed overnight against deionised water at 40C and 
freeze-dried. 
2.11 OTHER METHODS FOR THE SELECTIVE RELEASE OF 
pERIpLASMIC PROTEINS- 
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Methods for the release of periplasmic proteins from E. coli 
other than treatment with EDTA/lysozyme (see above) include 
osmotic shock techniques. In general, bacteria are first 
suspended in a concentrated solution of sucrose in EDTA and 
then removed to a medium of low osmotic strength. Two methods 
were used. The osmotic shock procedure of Neu & Heppel (1965) 
and Heppel (1968) were followed: Bacteria were grown in 
nutrient broth as before, harvested by centrifugation at 8K/20 
min/40C. The cells-were washed twice in a cold solution 
of 0.01M Tris-HC1 (pH 7.1) and 0.03M NaCl. The resulting cell 
pellet was resuspended in a solution of 0.03M Tris-HC1 (pH 8.0) 
and 10 
4M EDTA containing 20% sucrose (w/v) maintained at 
room temperature. The cells were collected by, centifugation 
(8K/10 min) and then rapidly dispersed in cold deionised-water. 
The mixture was agitated for 10 min at 40C. Release of 
periplasmic proteins occurred in the cold water wash. The 
mixture was centrifuged at 8K/20 min/40C the supernatant 
('shock fluid'), removed and freeze-dried. An alternative 
method for obtaining periplasmic proteins is by-the modified 
osmotic shock procedure of Willis et al., (1974). Cells were 
harvested at 150C and washed in a solution containing 
0.03M Tris-HC1 (pH 7) and 0.03M. NaCl. Cells were resuspended 
in 0.03M Tris-HC1 (pH 7) and the cells maintained at room 
temperature. An equal volume of 0.03M. Tris-HC1 - 2mM EDTA 
containing 40% sucrose was added. The cells were collected by 
centrifugation (8K/20 min/150C) and the plasmolysed cell 
pellet resuspended in 20m1 of cold dilute MgCl2 solution 
(10mM)" The mixture was centrifuged at 8K/20 min/4°C, the 
0 
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supernatant ('shock fluid') removed and after the addition of 
0.02ml of 2-mercaptoethanol the material was freeze-dried. 
2.12 ELECTROPHORESIS AND DETECTION OF POLYPEPTIDES 
2.12.1. One dimensional polyacrylamide gel electrophoresis 
a) Sample preparation 
one dimensional electrophoresis of both labelled and non- 
labelled proteins was performed in slabs of polyacrylamide gel 
in the presence of sodium dodecyl sulphate (SDS). All samples 
were prepared for electrophoresis by solubilization in the 
sample preparation buffer (SPB), similar to that described by 
Laemmli (1970), containing 0.2M Tris-HC1 (pH 6.8), 9.1% 
glycerol, 4.5% 2-mercaptoethanol, 1.3% SDS and 0.001% bromo- 
phenol blue. The temperature and time of solubilization 
routinely used were 1000C for 5 min unless otherwise 
indicated. Freeze-dried samples or cell fraction pellets were 
resuspended in SPB, heated for 5 min at'1000C, centrifuged 
and 50 - 100ul of the protein containing supernatant added to 
the gel. 
b) Fixed concentration running gels 
Gels containing 10% acrylamide were prepared from a stock 
solution of 29% by weight of acrylamide and 1% by weight of 
N, N'-bis-methylene acrylamide. Separating gels were composed 
of the following: - 16.5ml of 0.75M Tris-HC1 (pH 8.8), llml of 
30% acrylamide-bis-acrylamide solution, 0.5m1 of 10% freshly 
prepared ammonium persuiphate, 0.35ml of 10% SDS and 4.6ml of 
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deionised water per gel. The gels (33m1 volume) were 
polymerised chemically by the addition of lOul of tetra- 
methylethylenediamine (TEMED). 
c) Gradient running gels 
Alternatively, linear gradient gels. (5-20% acrylamide slabs) 
were prepared by following exactly the method described by 
Hams (1981). 
d) Stacking gels - 
The stacking gel (2cm long) for both 10% and gradient gels 
consisted of 5% acrylamide containing 4.2ml of 0.25M Tris-HC1 
(pH 6.8), 130u1 of 10% ainonium persulphate, 83u1 of 10% SDS, 
2.5m1 of deionised water and each gel polymerised by the 
addition of 3u1 TIIHED. 
e) Electrophoresis 
Electrophoresis was performed on slab gels (18 x, 16 x. 0.15cm) 
in a vertical electrophoresis tank (Bio-Rad Ltd. ) in cooled 
(150C) electrode buffer (pH 8.3) containing 0.025M 
Tris-HC1,0.192M glycine and 0.1% SDS (Laemmli, 1970). 
polypeptides were separated by the application of 30WV per gel 
with maximum voltage until the blue marker had run the complete 
length of the gel. 
f) Detection of proteins and estimation of polypeptide 
molecular weight 
_ 
Non-radioactive proteins were detected by staining the gel with 
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Coomassie brilliant blue R250 (Harnes, 1981) and then destaining 
it by repeated washing in a solution of 10% glacial acetic acid 
and 10% isopropanol. Labelled proteins were detected by auto- 
radiography under conditions where image intensity is directly 
related to the radioactivity in separated protein bands. The 
following proteins were used as molecular weight standards: 
Lysozyme (14K), carbonic anhydrase (29K), alcohol dehydrogenase 
(37K), fumarase (49K), bovine albumin (68K) and 
beta-galactosidase (130K) (all from Sigma). A mixture was 
prepared containing approximately 2mg of each of the above 
proteins in lml of the sample buffer prepared as above, 10-20u1 
applied to the gels and used to estimate the molecular weights 
of uncharacterised proteins. Scanning densitometry of 
separated polypeptides was performed with a Joyce Loebl 
Chromoscan 3 equipped with automated peak integration 
facilities. 
ý. 
2.12.2 Two dimensional lyacrylamide gel electrophoresis 
Two dimensional polyacrylamide gel electrophoresis (PAGE) was 
performed according to the method of Ames & Nikaido (1976) 
based on the procedure of O'Farrell (1975). 
a) Solubilization 
The solubilization procedure of Ames & Nikaido (1976) was 
followed. Protein (3mg) was solubilized at 1000C for 5 
min in 200u1 of SPB containing 0.1ml of 0.25M Tris HC1 (pH 
6.8), 0.2m1 of 10% SAS, 0.5m1 of lmN magnesium acetate, O. lml 
water and 0.1ml 2-mercaptoethanol. Eppendorf centrifuge tubes 
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containing samples were spun for 3 min (Microfuge, MSE, 
crawley, Sussex) and 300u1 of sample dilution buffer (SDB) 
containing 9.5M urea, 0.5m1 Ampholine (pH 3.5-10) (LKB Ltd. 
London), 0.8ml Triton X100,0.5ml 2- mercaptoethanol in 7.7ml 
of water added (similar to Ames & Nikaido (1976) but NP-40 
replaced by Triton X100). Solid sucrose (40%) was added to the 
final mixture and the samples kept cool until they were loaded 
onto gels. 
b) Isoelectricfocusing 
The first dimension (isoelectricfocusing) is as described by 
O"Farrell (1975). Gels composed of 2.75g urea, 0.7m1 of 30% 
acrylamide solution, lml of Triton X100, lml of water, 0.25ml. 
of Ampholine (pH 3.5-10) and 5ul of 10% ammonium persulphate 
were preparedin narrow bore glass tubes, -5ul of TEMED were 
added and the gels overlayed with 8M urea before polymerisation 
occurred. The tubes were mounted in a cylindrical gel 
apparatus and after removal of the urea, the samples were 
placed into the tubes by pipetting 50-150ul with a Hamilton- 
syringe. Ten to twenty ul of the sanple overlay solution 
(O'Farrell, 1975) were added to the tubes which were then 
filled with cathode electrode solution 0.02M sodium hydroxide 
(degassed by boiling). The anode reservoir was filled with 
0.01M H3PO4. Electrophoresis was performed at 400V 
for 18-20h. The cylindrical gels were'removed from the glass 
tubes, equilibrated in'a solution containing 125m1 of 0.25M 
Tris HC1 (pH 6.8), 50m1 of glycerol, 25m1 of 2-mercaptoethanol, 




gradient gel (5-20% acrylamide) was prepared as before except 
that the stacking gel was 2.5cm high and its top surface was 
flat. Equilibrated cylindrical gels were applied to the second 
dimension gel by placing them on the top buffer tank of the 
slab gel apparatus (Bio-Rad Ltd. ). Hot (50-600C) agarose 
(1% in equilibration buffer) was pipetted below and on top of 
the cylindrical gel taking care not to entrap air bubbles and 
electrophoresis was then performed at 30mA for 4-5h. Gels were 
either stained with Coomassie blue as before, or if the 
separation involved labelled protein, the dried gel was 
autoradiographed or fluorographed. 
2.12.3 Immunoblotting 
Samples containing outer membrane proteins were separated on 
10% acrylamide gels as before and transferred on to nitro- 
cellulose paper by the method of Towbin et al (1979). 
Following electrophoresis the gel was removed from the glass 
plates, equilibrated in buffer containing 0.025M Tris-HC1, 
0.192M glycine and 20% methanol for 30 min and proteins were 
transferred by positioning the gel on to a pre-wetted sheet of 
nitrocellulose paper (Bio-Rad Ltd. ) in a "transblot" apparatus 
(Bio-Rad Ltd. ) according-to, the manufacturer's instructions. 
Transfer was performed at 30V overnight and then 60V for one 
hour. The nitrocellulose paper was removed from the apparatus 
and to check if adequate transfer of protein had occurred the 
paper was soaked in a solution'of 0.1% amido black, 45% 
methanol and 10% glacial acetic acid. The paper was destained 
with a solution of 90% methanol and 2% glacial acetic acid. 
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To examine which proteins had been transferred, the "donor gel" 
was stained with Coomassie blue solution as previously 
described. Characterisation of the transferred proteins was 
carried out by a modification (Anwar et al., 1984) of the 
procedure described by Towbin et al., (1979). After 
electrophoretic transfer of the proteins, the nitrocellulose 
paper (not stained with amido black) was incubated with TBS 
(10mM Tris-HC1 in normal saline pH 7.4 ) containing 0.3% Tween 
20 for one hour to saturate the non-specific binding sites. 
The paper was saturated in antisera (anti-OmpF/C) diluted 1 in 
8 in TBS for 4 hours at 370C and then further incubated 
for 2. hours with horseradish peroxidase goat anti-rabbit-IgG 
conjugate (Sigma) diluted 1 in 2000 in TBS. Following 
incubation, the paper was washed thoroughly with TBS and 
visualised by using a solution of 25ug/ml of 4-chloro-l- 
naphthol in 10mM Tris-HC1 containing 0.01% hydrogen peroxide. 
2.13 PENICILLIN BINDING PROTEINS 
V VV ;: 
2_ 13.1 Labelling of penicillin binding proteins (PBPs) in 
cell envelopes treated with PMBN 
Zwo litres of bacteria were grown in nutrient broth to early 
logarithmic phase, cooled and harvested by centrifugation 
(9K/10 min/40C). Bacteria were resuspended in 60m1 of 
50mM sodium phosphate buffer (pH 7) and 0.75m1 of dithio- 
threitol solution (7.7 mg/ml) was added to each 15m1 of 
resuspended cells. Bacterial-suspensions (15m1) were sonicated 




removed by slow centrifugation (3K/30 min/40C). The 
pellet containing envelopes was washed several times in cold 
50mM sodium phosphate buffer (pH 7). The protein concentration 
of the envelopes was adjusted to approximately 10mg/ml and the 
envelopes dispensed in lml aliquots in Eppendorf centrifuge 
tubes. The envelopes were incubated with PMBN (200ug/ml final 
concentration) for 60 min at 370C with gentle shaking. 
Controls without PMBN treatment were included. -`The envelopes 
were recovered by high speed centrifugation (40K/60min 
/40C) and resuspended in buffer. Aliquots (100ul) were- 
treated for 15 min at 370C with benzyl (14C) 
penicillin (50 or 100uM concentration) as described by Spratt 
(1977) and the reaction was terminated by the addition of lOul 
of non-labelled benzyl penicillin (120mg/ml) and 5u1 of 20% 
Sarkosyl. Insoluble material'was removed by centrifugation 
(Microfuge, 20 min). Equal volumes of supernatant and x2 
concentrated SPB containing 300mg SDS, 7m1 of 0.25M Tris-HC1 
(pH 6.8), -3ml glycerol and 2m1 of 2-mercaptoethanol were mixed. ' 
' Finally, the samples were heated in the SPB for 5 min at 
1000C, spun (Microfuge, 1 min) and the supernatant (50 or 
100ul) loaded onto gels. 
2.13.2 Gel electrophoresis for separation of PBPs 
PBPs were separated by slab gel electrophoresis according to 
the procedure of Suzuki et al-(1978). Acrylamide gels (18 x 
16 x 0.15cm) were prepared from a stock solution of 29.5% (w/v) 
acrylamide and 0.5% (w/v) bis-acrylamide. The separating gel 
consisted of 16.5ml of 0.75M Tris-HC1 (pH 7.8), 8.25m1'of stock 
0 
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acrylamide solution, 7.35ml of deionised water, 0.5ml of fresh 
ammonium persulphate and 0.35m1 of 10% SDS. The gel was 
polymerised with lOul of TEMED. The stacking gel was prepared 
as before. Electrophoresis was at 30mV for 4-5 hours. After 
electrophoresis the gels were fixed in 10% acetic acid for a 
1-2h, washed thoroughly in water and prepared for''fluorography 
by soaking for 30 min in a solution of 1M sodium salicylate 
(Chamberlain, 1979). Gels were dried and placed in cassettes 
containing preflashed X-ray film. Cassettes were left for 6 
0 weeks at -50C before development of films. Labelled PBPs 
were quantified by densitometry'using the Joyce Loebl 
Chromoscan 3. 
2.14 LEAKAGE OF SMALL CYTOPLASMIC CONSTITUENTS FROM 
E. COLI 
The loss of various low molecular weight cytoplasmic 
constituents` from E. coli after exposure to'polymyxin Band 
PMBN was investigated. '- -, ', 
2.14.1 Leakage of amino acids 
Loss of free amino acids from the cytoplasmic pool was 
investigated with 
3H-labelled mixed amino acids using 
methods first introduced by Britten & McClure (1962). Bacteria 
were grown to early logarithmic phase and then incubated for 60 
min with chloramphenicol (100mg/ml) and 
3H 
amino acids 
(2uCi/ml) to form a labelled amino acid pool. Bacteria were 
harvested, washed and resuspended in 10mM sodium phosphate 
0 
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buffer (pH 7.4) to give a cell density of approximately 
1010/ml. The cell suspension was divided into equal 
aliquots and treated with the appropriate concentrations of 
polymyxin B or PMBN. Samples were removed at regular time 
intervals and processed rapidly to remove bacteria (Microfuge, 
3 min). To obtain a "total count", suitable volumes (250u1) of 
the supernatant were mixed with 20m1 of a scintillant 
consisting of 2-(4-tert-butylphenyl)-5-(4-biphenylyl) 1,3,4 
-oxadiazole (butyl-PBD 6g), Triton X100 (500ml), toluene (11) 
and deionised water (150ml). The total radioactive count 
represents both free labelled amino acid and radioactivity 
incorporated into protein. An equal volume of the supernatant 
was dispensed into cold 10% trichioroacetic acid solution 
(TCA), maintained on ice for 30 min and filtered through GF/C 
glass fibre filters (Whatman 2.5cm). Filters were washed with 
two volumes of 10% TCA and three volumes of 1% acetic acid, 
dried and placed in scintillation vials. lOml of a scintillant 
consisting of butyl-PBD without Triton were added. -The 
radioactivity of. the TCA precipitate is a measure of 
incorporation of, labelled amino acids into protein. Thus, the 
radioactivity released from the soluble pool. was calculated by 
subtracting the quantity of labelled amino acids incorporated 
into protein from the-total (Britten & McClure, 1962). 
2.14.2 Leakage of uracil 
Release., of free (pool) uracil fron E. coli was investigated 
with 6-3H labelled uracil. Bacteria were grown to early 
logarithmic phase and then incubated with 6-3H-uracil 
h 
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(2uCi/ml) for 45 min to form a labelled uracil pool. The 
bacteria were harvested and exposed to antibiotics, samples 
removed at regular intervals and processed as described in 
section 2.14.1. Free labelled uracil in the cell-free 
supernatants was quantified according to the method of 
Dougherty & Saukkonen (1985), which is essentially similar to 
the method used above to quantify loss of pool amino acids. 
2.14.3 Release of potassium ions 
Potassium leakage was measured essentially according to 
Lannigan & Bryan (1985) using a model 93-3199 potassium 
specific electrode (Russell Ltd. Auchtermuchty, Scotland. ) 
coupled to a Digital 110 millivolt recording meter (Corning 
Scientific Instruments, Medfield, Massachusetts). The 
potassium electrode was calibrated and used according to the 
manufacturer's-instructions; a calibration curve was 
constructed in the presence of O. O1M NaCl to give a'suitable 
background ionic strength for low level measurements. 'A 
solution of potassium chloride (O. 1M)'in deionised water was 
prepared and diluted to givea range'of concentrations from 
lx10-3M to 1x10-6M. Appropriate volumes of "ionic - 
strength adjuster" (NaCl)'were'added and the electrode 
potential (in mV) recorded for each concentration. It was 
confirmed that plots of potassium chloride'concentration (log) 
against electrode potential were linear (data not shown). 
Bacteria were grown in nutrient broth, harvested at room 
temperature and washed in 10mM sodium phosphate buffer (pH 
7.4). The cells were resuspended in the buffer to give 
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approximately 1010 cells/ml. Aliquots (50m1) of the cell 
suspension were taken and equilibrated at 370C for 10 min. 
Suitable volumes of the antibiotic under test were added 
rapidly to the cells and mV readings taken at frequent 
intervals until no further change was noted. The concentration 
of potassium released was determined from the low-level 
calibration curve. 
2.15 ELECTRON MICROSCOPY 
i0 
2.15.1 Preparation of cells for transmission' electron 
microscopy 
a) Treatment of cells with antibiotics 
E. coli K12 3300 (pBR322) were grown to mid-logarithmic phase 
in nutrient broth, harvested by centrifugation at 3K/10 min/ 
40C, washed twice in 100mM filtered cold sodium 
phosphate buffer (pH 7.4) and then resuspended in'the same 
buffer to a cell density of 1010/ml. The cell suspension 
was divided into three aliquots. At'time zero-polymyxin B 
(200ug/ml) was added to one portion- and d-PMBN (200ug/ml) to the 
second. The third aliquot-served-as an untreated control. 
Bacteria were incubated at 370C with shaking on an orbital 
shaker (50-75rpm). Samples were removed at--O, 15,30 and 60 
min after the addition of antibiotic, centrifuged at 3K/5 min 
and washed in 100mM sodium cacodylate buffer (pH-7.2). 
b) Fixation i 
Cells were resuspended in the same buffer containing 2.5% 
glutaraldehyde (E. M. grade) and left to fix atýroom temperature 
p 
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for at least one hour. The cells were spun at 3K/5 min at room 
temperature, washed twice in 100mM sodium cacodylate buffer and 
treated with 1% osmium tetroxide (TRAB Laboratory Equipment 
Ltd., Reading) for 1 hour. The cells were spun at 3K/ 5 min 
and stored at 40C. 
c) Processing of cells using bovine serum albumin (BSA) 
Osmium-treated cells were resuspended in a solution of-50mM 
Tris-HC1/0.15M NaCl (pH 7.2), spun at 3K/5 min and resuspended 
in 0.2m1 of a solution of 50mM Tris-HC1 with 4% BSA (pH 7.2). 
To form a solid pellet of cells, 20u1 of 25% glutaraldehyde was 
added, the suspension mixed and quickly transferred toýa Beem 
capsule (size 00 G363-1 hyperbolic, Agar Aids Ltd., Cambridge 
Road, Stanstead, Essex). The Beem capsule was placed within a 
centrifuge tube and spun at 4K for at least 5 min. The pellet 
at this stage had formed a cross-linked gel, which encapsulated 
the bacterial cells and could be removed from the capsule and 
sliced thinly into lmm curved pieces in 70% alcohol. The 
samples were dehydrated with 90% alcohol and transferred 
through three changes of 100% alcohol (silicä-gel dried). - The' 
samples were transferred initially to 100% propylene. oxide (10 
min), then to a solution containing 50% propylene oxide and 
embedding resin (TRAB Laboratories Ltd. ),,. -, for 30 min and 
thirdly to a solution containing 25% propylene oxide and resin 
(30 min). Finally samples were transferred to 100% resin and 
left overnight with gentle agitation on aýrotator (Type N, TAAB 
Laboratories Ltd. ). The samples were transferred to fresh 
resin for 4-5 hours and then transferred to resin filled Beem 
capsules (size 00 G360-1 TRAB Laboratories Ltd. ) and 
A 
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polymerised overnight at 600C. Embedding resin was 
prepared by mixing 50g of resin with hardeners; 38g of 
Dodecenyl succinic anhydride (DDSA) and 12g of Methyl nadic 
anhydride (MNA).. The polymerisation catalyst DMP-30 was added 
to the mixture (1.8g). 
d) Thin section cutting 
Knives for cutting ultra thin sections were prepared from glass 
strips (25 x 5mm., LKB Bromma 7890-04) with a knifemaker (LKB 
Type 7801B). Thin sections (1`micron thick) were cut from 
trimmed resin with the LKB Ultrotome III and collected in a 
e 
truf" (LKB 2280-100) containing filtered water. The sections 
were heat fixed on a glass slide and stained with warmed 0.25% 
Azure II and 0.5% borax solution, dried and examined under the 
light microscope. For ultra thin sections, the automatic feed 
system on the Ultrotome was employed. This allowed the'machine 
to advance'70nm at-'a time and the'thickness of-sections could 
be assessed by optical interference. Sections demonstrating 
silver or-gold were of an optimal' thickness, whereas purple 
sections were not acceptable. Ultra thin sections were mounted 
on copper/rhodium grids for electron microscopy (HR25; 300 mesh 
x 3mm, Graticules Ltd., Tonbridge, Kent). The sections were 
allowed to dry on the grids to await staining. 
e) Staining for the Transmission Electron Microscope (TEM) 
A saturated solution of'uranyl acetate in 70% alcohol was 
shaken well and filtered through a 0.2u disposable filter (Flow 
Laboratories Ltd., -Irvine, Scotland). 'A few drops were placed 
on parafilm and the grid (surface containing sections in 





Subsequently, the grid was washed, first with 70% alcohol and 
then with double deionised water. Reynolds lead citrate was 
prepared as shown below, filtered and a few drops placed on 
parafilm in a petri dish containing filter paper wetted with 
sodium hydroxide (NaOH) to absorb the carbon dioxide. The grid 
containing sections were placed on the lead citrate solution 
for a maximum of 10 min, washed with 0.024 NaOH and then with 
double deionised water. The grids were blotted and left to 
dry. The sections were examined. with a Philips 300 
Transmission Electron Microscope-and micrographs taken with a 
35mm camera using Kodak fine grain positive. film unperforated 
(Agar Aids Ltd. ). Reynolds lead citrate was prepared by adding 
30ml of freshly boiled deionised water to 1.33g of lead nitrate 
and 1.76g of sodium citrate, mixed and placed at room 
temperature-for 30 min. A 1M solution of NaOH (8m1) was added 
and the solution made up to 50m1 with boiled water. 
2.15.2 Scanning electron microscopy 
a) Treatment of cells with antibiotics 
For scanning electron microscope (Sm) studies, bacteria were 
either grown,, harvested and resuspended to give a cell density 
of 1010 cells/ml and treated with antibiotics as described 
in 2.15.1, or alternatively 20u1 of an undiluted overnight 
broth culture were added to 2ml of filtered nutrient broth . 
containing the appropriate concentration of antibiotic. 
Bacteria were incubated at 370C without shaking and 
samples removed at 0,15 and 60 min. Cells were fixed in 2.5% 
glutaraldehyde and 1% osmium tetroxide as described previously 
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-for TEM fixation. After fixing, cells were washed in 100mM 
sodium cacodylate buffer (pH 7.2), resuspended and stored in 
this buffer. 
b) Preparation for SEM 
Apparatus containing a 0.4um cellulose acetate filter (13mm 
diameter, Sterilin Ltd., Feltham, Middlesex) was assembled and 
the cells collected on the filter. The filter was dehydrated 
through. a series of alcohol washes in a 24 well plastic 
multidish (Flow Laboratories Ltd. ). The filter was carefully 
transferred through 30%, 50%, 70%, 80%, 90% and two transfers 
in 100% ethanol, allowing 5 min in each solution. Using a 
small filter paper folded into the shape of an envelope, which 
had been soaked in ethanol, the filter was transferred, under 
ethanol, and secured with a staple. This procedure allowed the 
filter containing the cells to be kept flat and allowed 
exchange of fluids to take place. The envelopes at this stage 
were subjected to critical point drying after which, specimens 
were retrieved and mounted, using double sided sellotape, onto 
aluminium stubs (Polaron Equipment Ltd., Watford, Herts. ). The 
filters were coated with platinum using a sputter coater 
(Emscope Ltd., Ashford, Kent) and examined with a Philips 501 
Scanning Electron Microscope. Photographs were taken with 






CHARACTERISATION OF POLYMYXIN B NONAPEPTIDE 
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INfl RODUCTION 
The work reported in this thesis has been directed primarily to 
obtaining a better understanding of the mode of action of PMBN 
(see subsequent chapters). The purpose of the experiments 
described in this chapter have been to establish that PMBN of 
the highest purity could be prepared. Clearly this is an 
essential prerequisite before conducting detailed studies on 
its mode of action. 
Reahonable quantities of polymyxin B nonapeptide were' 
produced from commercially available polymyxin B by the removal 
of the fatty acyl group and the terminal diamino-butyric acid 
residue by the proteolytic enzyme ficin following the procedure 
of Chihara et al., (1973) (fig 3.1). The data reported in 
this chapter characterises PMBN and describes its detailed 
analysis by a variety of chemical means. Confirmation of 
PMBWs lack of antibacterial activity but its ability to 
sensitise E. Coli to some antibiotics is outlined. 
A number of biophysical techniques 1have been used to 
characterise polymyxin B and PMBN. A brief description of each 
of these techniques is now provided. 
Thin-layer chromatography is the easiest of all chromato- 
graphic methods for separating the products of a reaction and 
requires only simple and inexpensive equipment. The components 
of a mixture separate by migration at different rates in the 
mobile phase (solvent) through a cellulose alumina matrix. 
(e. g. see Sherma & Fried, 1984), the separated components being 
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Fig 3.1 Structural formulas of polymyxin B and its derivative 
PNBN, prepared by. enzymic ficin treatment. 
Abbreviations: dab = diaminobutyric acid; phe = phenylalanine; 
thr = threonine; leu = leucine; 
FA = fatty acyl group (6-methyl octonoic acid). 
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High pressure liquid chromatography is the preferred 
technique for improved resolutions of mixture separations. 
High pressure (or performance) liquid chromatography involves 
movement of the mixture in a high velocity mobile phase (e. g. 
see Engelhardt, 1979). A narrow bore column is used and is 
packed with particles having an average diameter of less than 
50um. The efficiency of the separation depends in part on the 
size of column and particles. 
Nuclear magnetic resonance spectroscopy has become 
established as a powerful technique for molecular structure 
elucidation. Based upon the principle of absorption and 
remission of radiofrequency radiation by atomic nuclei of 
substances placed in a strong magnetic field (e. g. see Roberts 
& Jardetzky, 1985). NMR spectroscopy has been used as an 
" analytical tool to determine the. precise molecular structure of 
many organic compounds. 
Ultraviolet and visible spectroscopy; The ultraviolet or 
visible spectra of compounds are shown normally as a plot of 
the light absorbed by the compound against wavelength. 
Absorption spectra in the visible (400-700nm) or ultraviolet 
(200-400nm) are due to energy transitions of outer electrons of 
the molecule. Spectral analysis of such compounds involves the 
recording of specific absorption peaks (e. g. see Chopra, 1985a) 
and allows the identification and comparison of compounds of 




3.1 PURITY AND YIELD OF PMBN 
The identity and purity of the product obtained by ficin 
treatment of polymyxin B was checked by a number of techniques 
including TLC, NMR, HPLC and spectral analysis. 
3.1.1 Thin-layer chromatography -" 
Examination of TLC plates following development of spots with 
ninhydrin showed that the reaction product had a different 
Rf from that of polymyxin B or ficin (data not shown). On 
the basis of previous thin-layer chromatography data (Vaara 
& 
Vaara, 1983a) the product was presumed to be PMBN. 
3.1.2 Spectral analysis 
The spectral profiles of polymyxin B and the compound presumed 
to be PMBN also differed. Polymyxin B displayed four distinct 
absorption peaks in the 250 to 270nm range at wavelengths of. 
251.4,257.4,263.4 and 266.6nm (see fig 3.2a). The compound 
presumed to be PMBN was clearly related to polymyxin B because 
it possessed the four absorption peaks described above. 
However, it differed from polymyxin B by exhibiting an 
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Fi 3.2 Wavelength scan profiles of (a) polymyxin B and 
(b) 
PNIBN solutions obtained by transfer of data from a PU8800 
spectrophotometer to a B. B. C. microcomputer (see text). 
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3.1.3 Nuclear magnetic resonance spectroscopy 
Confirmation of the identity of PNBN was obtained by nuclear 
magnetic resonance spectroscopy (NMR). The signals 
corresponding to the terminal methyl groups and the methylene 
chain of the fatty acyl residue of polymyxin B were absent from 
the product of ficin degradation and were replaced by signals 
corresponding to a terminal threonine (figs 3.3 and 3.4). 
These results are entirely consistent with the published 
structure of PMBN (Vaara & Vaara, 1983c). 
3.1.4 High pressure liquid chromatography 
Comparison of PMBN and polymyxin-B by HPLC demonstrated that 
they had different retention times. A solution of 100ug/ml PMBN 
(20u1) injected into the column produced a distinct 
peak almost immediately (see fig 3.5b), whereas an equivalent 
concentration of the polymyxin B solution produced a different" 
profile with the retention time of the major peak delayed 
(fig 
3.5a). Quantitative HPLC showed that batches of PMBN contained 
no more than 0.4% polymyxin B (data not shown). The, PMBN yield 
was typically 70%. 
3.2 PMBN STABILITY 
NMR analysis of samples of-PMBN which had been prepared two 
years previously and stored at 40C in dry conditions, 
showed that the material did not markedly deteriorate in this 
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Fig .5 Analytical HPLC traces of (a) polymyxin B and (b) 
b) 
pMBN with absorbance at 210nm plotted against retention time. 
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3.3 THE ANTIBACTERIAL ACTIVITY OF PMBN 
Compared with polymyxin B, PMBN is reported to have very low 
intrinsic antibacterial activity (Vaara & Vaara, 1983b and c). 
These findings were confirmed in the present studies by showing 
that the MIC value of polymyxin B for E. coli K12 3300 
(pBR322) was 0.25ug/ml whereas PMBN was at least 300-fold less 
active (M IC >100ug/ml). 
3.4 SYNERGISM BETWEEN PMBN AND HYDROPHOBIC ANTIBIOTICS 
PNIDN potentiates the action of hydrophobic antibiotics against.. 
Gram-negative bacteria_(Alatossava et al., 1984; Vaara & 
Vaara, 1983c and Viljanen & Vaara, 1984). The PMBN used in 
these studies enhanced the activity of. fusidic acid against 
E. coli K12 3300 thereby confirming the reports of 
potentiation by other workers. In a checkerboard titration of 
PMBN and fusidic acid (sodium salt)*, the 4IC of fusidic acid 
fell from 320ug/ml in the presence of 0.5ug of PMBN per ml to 
5ug/ml in the presence of 4ug of PMBN per ml (fig 3.6). 
Furthermore, the pattern of inhibition of growth obtained (fig 
3.6) is characteristic of synergy between the two compounds 
(Krogstad & Moellering, 1980). Similar results were obtained 
with checkerboard titrations of PMBN and benzyl pefiicillin 
(data not shown). The results obtained with PMBN were not 
sinply due to residual contamination with polymyxin B, because 
checkerboard titrations with polymyxin B in the range 2-32 
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Fig 3.6 Minimum inhibitory concentrations of sodium fusidate 
(ug/ml) against E. coli K12 3300 (pBR322) in the presence of 
PMBN (0.5-8ug/ml). Graphical representation of typical 
results obtained in a checkerboard titration of sodium 
fusidate and PMBN. 
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with polymyxin B, i. e. 0.4%) failed to'decrease the fusidic 
acid or benzyl penicillin M IC value (data not shown). 
3.5 VIABILITY OF E. ODLI K12 3300 (pBR322) AFTER EXPOSURE TO 
POLYMYXIN B OR PMBN 
Viability determinations following exposure to polymyxin B or 
PNBN were performed on E. coli K12 3300 (pBR322) suspended at 
cell densities of 1010 cells per ml in 10mM sodium 
phosphate buffer (pH 7.4). Treatment with 200ug/ml of 
polymyxin B led to rapid bacteriolysis (fig 3.7) whereas an 














F 3.7 Viability of E. coli K12 3300 (pBR322) after 
exposure to polymyxin B or PMBN: Polymyxin B (" ) 
200ug/ml; PMBN (0) 200ug/ml; Untreated controls (0 ). 
Values are the means of replicate determinations. 





Chemical analysis of PMBN preparations confirmed the reported 
structure of PMBN. Spectral analysis of both PMBN and 
polymyxin B showed that PMBN could be distinguished from its 
parent by characteristic absorption spectra. Inaddition, the 
application of NNR spectroscopy has provided the first direct 
evidence that the structure of PMBN is as predicted by Vaara & 
Vaara, (1983a), and that the compound exhibits a terminal 
threonine residue in place of the terminal diaminobutyric acid 
(dab) residue and fatty acyl chain removed by ficin. Vaara & 
Vaara, (1983a and b) omitted to report any physical methods of 
analysis to elucidate the structure of PMBN. ` 
PMBN prepared for this study has been subjected to 
considerable purity analysis. Previous reports by Vaara & 
Vaara, (1983a and b) have described the TLC analysis of ficin- 
treated polymyxin B demonstrating the product PMBN and 
pölymyxin B as separate spots. This present study has 
confirmed. the findings of these workers but in addition has 
extended the purity analysis of PMBN using HPLC, a superior 
high resolution technique to TLC. 
To study PMBN action it has'been important to exclude the 
possibility that changes affecting permeability of the envelope 
were not due simply to low levels of contaminating polymyxin B. 
As previously outlined the outer membrane of Gram-negative 
bacteria is essentially the primary target for disruption by 
polymyxin B and its integrity may well be affected by very low 
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levels of the antibiotic. Indeed, sublethal concentrations of 
polynyxin B (0.3ug/ml) have been reported as responsible for 
the slight sensitisation of E. coli to fusidic acid (Vaara & 
Vaara, 1983a). Investigations of the purity of PMBN by HPLC 
techniques have given a quantitative estimate of organic 
contamination, especially with respect to polyryxin B. The 
extent of polymyxin B contamination of PMBN preparations was 
very low (<0.4%). Residual polymyxin B contamination is 
therefore unlikely to account for changes in permeability 
11 induced by PMBN preparations. 
The microbiological results presented in this chapter 
have also confirmed 1) some of the fundamental features of PMBN 
action, i. e. the ability of PMBN to sensitise polymyxin 
-susceptible organisms such as E. coli to various hydrophobic 
antibiotics (Alatossava et al., 1984; Vaara & Vaara, 1983c; 
Viljanen & Vaara, 1984; and Lam et al., 1986) 2) the poor 
antibacterial activity of PMBN. against E. coli compared to the 
parent compound polymyxin B (Vaara & Vaara, 1983a and b) 3) 
that relatively high concentrations of PMBN failed to kill 
cells whereas polymyxin B was highly bacteriolytic (Vaara & 
Vaara, 1983b). It was shown, however, that although PMBN 
failed to kill cells during treatment, a number of biochemical 
parameters (detailed in later chapters) were altered. 
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CHAPTER 4 
EFFECTS OF POLYMYXIN B NONAPEPTIDE AND POLYMYXIN B 
ON TUE CELL ENVELOPE STUDIED BY PROTEIN LEAKAGE 
67 
IIn1 DD[JGTION 
The previous chapter described the characterisation of PMBN and 
the initial experiments that confirmed its ability to sensitise 
E. coli to some hydrophobic antibiotics without_killing the 
cell. This chapter deals with aspects of, 
_the 
interaction of`' 
Pt3N with the E. coli cell envelope.,. 
The outer membrane of Gram-negative organisms acts as a 
permeability barrier. to macromolecules including hydrophobic 
antibiotics (Nikaido & Nakae, 1979). 
__ 
Although the mechanism 
leading to the loss of. the barrier function to hydrophobic, 
antibiotics is unknown, it would seem reasonable to suppose 
that some degree-of perturbation of the outer membrane has 
taken place, and this may be reflected by the leakage of 
proteins from the periplasmic region. Several approaches have 
been taken. to_investigate the outer membrane as a functional 
barrier. Firstly, exposure of cells to EDTA increases the 
permeability, by chemical means, of a wide. range of Gram- 
negative bacteria to many compounds (Hancock,, 1984). 
Treatment of E. coli with EDTA enhances passage of hydro- 
phobic antibiotics through the cell envelope, (Leive, 1974) 
resulting in concomitant loss of periplasmic proteins through 
the damaged outer membrane (Cerny 
,& 
Teuber, 197,2). Secondly, 
deep rough lipopolysaccharide mutants that are hypersensitive 
to hydrophobic antibiotics also release periplasmic proteins 
into the medium (Nikaido & Vaara, 1985). These general 
features are illustrated in fig 4.1. Treatment of E. coli 
With PMBN, however, does not apparently cause leakage of 
Fig 4.1 'Hypothetical structure of*outer membrane in 
the wild-type, deep rough mutants and EDTA-treated 
wild-type cells of E coli. 
A) Wild-type strain in which the outer layer is almost 
entirely composed of LPS and protein. Periplasmic 
proteins (® ) are restricted to the cell. 
B) Deep rough mutants. Hydrophobic molecules ( ©) are 
assumed to penetrate through the phospholipid bilayer 
domains. Periplasmic proteins can apparently leak 
through this area. 
" C) Deep rough mutants. Hydrophobic molecules are 
assumed to penetrate through the LPS domains which 
become more permeable due to alterations in LPS 
structure. Periplasmic proteins can apparently leak 
through this area. 
D) EDTA-treated wild-type cells. Phospholipid 
molecules are assumed to fill the void left by the 
selective removal of LPS by EDTA. Small amounts of 
periplasmic proteins leak after this treatment. 



























proteins from the cell (Vaara & Vaara, 1983b and Nikaido & 
Vaara, 1985). This would seem to be an unusual feature since 
the compound can enhance uptake of hydrophobic antibiotics. 
Despite reports to the contrary (Vaara & Vaara, 1983b and 
Nikaido & Vaara, 1985) PMBN may indeed cause loss of 
periplasmic proteins from Gram-negative bacteria accompanied by 
changes in the permeability of the outer membrane to 
hydrophobic antibiotics. 
In this chapter the possibility that PMBN promotes 
periplasmic protein leakage in E. coli has been re-examined. 
The activity of PMBN in this respect was compared directly with 
that of polymyxin B, which is known to cause release of 
periplasmic proteins (Cerny & Teuber, 1971 and 1972; Storm et 
al., 1977 and Vaara & Vaara, 1981). 
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Figy4. 
_2 
Core region of E. coli K12 lipopolysaccharide 
(from Hammond et al 1984). 
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RESULTS 
4.1 POLYMYXIN B AND PMBN-INDUCED RELEASE OF MACROMOLECULES 
FROM E. COLI 
4.1.1 Lipopolysaccharide 
It is well established that KDO is a component of E. coli LPS 
(fig 4.2). Possible loss of LPS following treatment of 
bacteria with polymyxins was assessed by assaying for KDO in 
cell-free supernatants (Karkhanis et al., 1978). There was 
no evidence that these. compounds promoted release of LPS (data 
not shown). 
4.1.2 Proteins; the kinetics of leakage and cell 
compartments from which proteins are lost. 
Concentrated suspensions of E. coli K12 3300 (pBR322) were 
exposed to polymyxin B (200ug/ml) or PMBN (200ug/ml), and the 
release of protein was determined from cell-free supernatants 
at various times after exposure to the compounds. Polymyxin B 
caused release of about 100ug/ml of protein per ml of - 
supernatant after 1 min, reaching a maximum of about 180ug/ml 
after 45 min (fig 4.3). PMBN also caused loss of protein 
within the first minute. - However, the quantity of protein 
released was less than that from polymyxin-B-treated cells 
(fig. 4.3). . Untreated bacteria failed to release-detectable 
quantities of protein (fig 4.3). 
- To examine whether released protein originated from either 



























Fig 4.3 Polymyxin B and PMBN-mediated release of protein from 
E. coli K12 3300 (pBR322). Cell suspensions were divided into 
three samples. At time zero polymyxin B (200ug/ml) was added 
to one portion (") and PMBN (200ug/ml) (0) to the second. 
The third sample served as an untreated control (Q ). 
Bacteria were incubated at 3700 and samples removed at the 
times indicated. Samples were processed rapidly to remove 
bacteria, followed by estimation of protein in the cell-free 
supernatant. Values are the means of duplicate 
determinations. 















Fig 4.4 Polymyxin B and PMBN-mediated release of 
beta-lactamase from E. coli K12 3300 (pBR322). 
The experiment was conducted as described in the legend to 
fig 4.3 except that the cell-free supernatants were assayed 
for beta-lactamase activity: Polymyxin B(") 200ug/ml; 
PMBN (O) 200ug/ml; Untreated control Q ). Values are the 
means of duplicate determinations. 






















Fig 4.5 Polymyxin B-mediated release of beta-galactosidase 
from E. coli K12 3300 (pBR322). The experiment was conducted 
as described in the legend to fig 4.3 except that the 
cell-free supernatants were assayed for beta-galactosidase 
activity: Polymyxin B(O) 200ug/ml; PMBN (0) 200ug/ml; 
Untreated control (p ). Values are the means of duplicate 
determinations. ONP = -nitrophenyl-B-D-galactopyranoside. 
15 30 45 60 
TIME(min) 
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assayed for beta-lactamase (periplasmic) and beta-galactosidase 
(cytoplasmic). Polymyxin B treatment caused immediate release 
of beta-lactamase which was complete within 5 min of exposure 
to the antibiotic (fig 4.4). After 60 min this represented 
release of 62% of the cellular beta-lactamase activity. An 
equivalent concentration of P BN (200ug/ml) also caused 
beta-lactamase release (fig 4.4). The kinetics of polymyxin B 
and PMBN-mediated release were similar, but the level of enzym 
released by PMBN was about seven-fold lower than that liberate 
by polymyxin B (fig 4.4). Untreated bacteria also showed no 
release of beta-lactamase. The results obtained with PMBN wer 
not due sinply to contamination with polymyxin B because 
exposure of bacteria to 0.8ug/ml of polymyxin B (representing 
the maximum level of contamination of PMBN with polymyxin B) 
caused no detectable protein or beta-lactamase release. 
Polyrrryxin B also caused release of beta-galactosidase int 
the supernatant, although release of the enzyme was not 
detected until the bacteria had been treated with polymyxin B 
for 15 min (fig 4.5). In contrast, PMBN-treated bacteria 
failed to release beta-galactosidase even after treatment for 
60 min and in this respect their behaviour was similar to that 
of untreated bacteria from which there was also no release of 
enzyme (fig 4.5). 
4.2 PROTEIN LEAKAGE : ANALYSIS BY GEL ELEMOPHC2ESIS 
The results described in the previous section suggest that 




Table 4.1 Comparison of polypeptide profiles by single 
linkage clustering analysis. The presence or absence of 31 
individual peaks from each gel profile was recorded. 
Percentage similarity of the profiles was calculated by 
computer program and shown above as a dendrogram. Comparisons 
of the following fractions from E. coli K12 3300 (pBR322) are 
shown: - A) periplasmic proteins; B) polymyxin-released 
proteins; C) PMBN-released proteins (as shown in figs 4.6 and 
4.7) and D) outer membrane. 
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to be derived from the periplasmic region. Some of the 
proteins released by polymyxin B are also likely to be 
periplasmic, but in addition cytoplasmic proteins are probably 
released by exposure to the antibiotic. To confirm these 
suggestions and also to establish whether outer membrane or 
cytoplasmic membrane proteins might also be released by either 
of the compounds, further experiments were conducted in which 
released proteins were analysed by gel electrophoresis and the 
profiles compared with those obtained fron separately prepared 
cell fractions. 
Proteins from the cytoplasmic (inner) membrane, 
periplasmic and outer membrane fractions were compared with 
those released by polymyxin B or PMBN after exposure to the- 
compounds for 60 min. The degree of similarity between the 
various preparations was estimated on the basis of both 
polypeptide migration measurements (obtained with the Joyce 
Loebl scanning densitometer) and the overall profiles exhibited 
by each sale. The degree of similarity of protein profiles 
from various cell fractions was further assessed by single 
linkage clustering analysis. The polypeptides released by 
polymyxin B (after 60 min) showed a high degree of similarity 
with periplasmic proteins (fig 4.6) and less resemblance to 
proteins contained in the other cell fractions (data not 
shown). This-was consistent with the findings of Cerny_& 
Teuber (1971. and. 1972) and was confirmed by clustering analysis 
shown in table 4.1. 
Proteins released by PMBN (after 60 min) also appeared to 
be periplasmic (fig 4.6) which was further confirmed by showing 
Fig 4.6 Comparison of polypeptides released by 
polymyxin B (lane b) and PNBN (lane e) with 
periplasmic proteins (lane"a) and pBR322-encoded 
proteins synthesized in minicells (lane d). 'E. coli 
K12 3300 (pBR322) cells (1010/ml of phosphate buffer) 
were treated with polymyxin B (200ug/ml) or PMBN 
(200ug/ml) for 60 min. Proteins released into 
cell-free supernatants were electrophoresed. - '°" 
periplasmic proteins were also prepared (see text) and 
separated (lane a). Minicells containing pBR322 were 
labelled with [35S]-methionine and coelectrophoresed 
(lane c) with the other samples. After 
electrophoresis proteins in lane a, b, c, and e were 
detected with Coomassie blue. The gel was', then dried, ' 
and labelled polypeptides in lane c were detected by 
autoradiography. The X-ray film was aligned'overlthe"'-"°" 
dried stained gel to locate lane d (labelled-proteins) 
between lanes c and e. A composite photograph was 
taken to provide the figure shown. Numbers 1 -6 on 
the left refer to six principal polypeptides (see 
text). Molecular weights are shown on the right. 
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that the profiles had little resemblance to the other cell 
fractions (table 4.1). However, PMBN clearly differed from 
polymyxin B with respect to the release of individual 
periplasmic polypeptides (fig 4.6). The periplasmic fraction- 
(lane a fig 4.6) prepared by the lysozyme/EDTA method of Yamato 
et al (1975) contained six principal polypeptides (numbered 1 
to 6) with molecular weights of between about 29K and 62K. 
Treatment with polymyxin B for 60 min led to considerable 
release of periplasmic polypeptides 1,2 and 5 with some 
release of polypeptides 4 and 6 as well as other minor 
periplasmic proteins (c. f. lanes a and b fig 4.6). PMBN 
released polypeptides 3 and 4 and traces of polypeptides 1 and 
6 (c. f. lane e fig 4.6). Therefore, the ability of these 
compounds to release the major periplasmic proteins varied. 
The most characteristic features being the capacity of PMBN to 
release polypeptide 3 but not 2 and 5 whereas polymyxin B could 
release 2 and 5 but not 3. The polypeptides released from cells 
exposed to polymyxin B for 15 and 60 min were quantitatively 
identical, with no evidence of additional bands appearing at 60 
min that were absent from the samples taken at 15 min (fig 
4.7). The poly- peptide profiles of supernatants taken after 
15 and 60 min exposures to PMBN were also quantitatively 
identical (fig 4.7). Furthermore, the ability of PMBN to 
promote the release. of similar polypeptides to those above, 
from other strains of Ecoli was noted. E. coli K12 DCO 
described by Curtis et al., 1979a and b) produced a 
coriparable polypeptide profile of released polypeptides to that 
of E. coli K12 3300 (pBR322) (data not shown). 
Fig 4.7 Comparison of polypeptides released 
following treatment with polymyxin B or PMBN after 15 
or 60 min. E. coli K12 3300 (pBR322) was treated and 
prepared as described in the legend to fig 4.6. 
Periplasmic proteins (e) were prepared as described in the 
text. The polypeptide profiles of cell-free 
supernatants after treatment with PMBN (200ug/ml) for 
15 min (a) or 60 min (c); or polymyxin B (200ug/ml) 
for 15 min (b) or 60 min (d) are shown. Numbers 1-6 






4.3 PARTIAL CHARACTERISATION OF PROTEINS RELEASED BY 
POLYMYXIN B and PMBN 
The active form of pBR322-encoded beta-lactamase migrates as a 
28,500 (28.5K) molecular weight polypeptide-in polyacrylamide 
gels (Kopylova-Sviridova et al., 1979). Periplasmic 
polypeptide 6 (figs 4.6 and"4.7) therefore probably represents 
beta-lactamase. To confirm this, minicells from DS410 (pBR322) 
were prepared and plasmid-encoded proteins labelled with- 
35 S1 methionine. Labelled preparations were 
co-electrophoresed with non-labelled periplasmic proteins 
together with preparations obtained after treatment with 
polymyxin 3 and PMBN (fig 4-. 6). The major labelled products in 
minicells containing pBR322 were 28.5K and 34K proteins, 
corresponding respectively to the pBR322-encoded beta- 
lactamase and the cytoplasmic membrane protein responsible for 
tetracycline efflux (Kopylova-Sviridova et al., 1979 and 
Chopra, 1985a). -Periplasmic polypeptide 6 (lane a fig 4.6) 
co-migrated with-the labelled beta-lactamase synthesised in 
minicells (lane d fig 4.6). As noted above periplasmic 
polypeptide 6 was released by polymyxin B, whereas only trace 
amounts of this polypeptide were released by PMBN (the level of 
polypeptide'6 released by'PMBN"is too low to be reproduced in 
lane e of fig 4.6). These observations are also consistent 
with the identification of polypeptide 6 as beta-lactamase 
because polymyxin B released more of this enzyme than did PMBN 
(fig 4.4). PMBN failed to release detectable quantities of 34K 
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polypeptides (fig 4.6), indicating that the pBR322-encoded 
tetracycline efflux protein was not released from the 
cytoplasmic membrane. 
In conventional PAGE, the OmpF/C complex (porins) is 
difficult to resolve and appears normally as a single band. 
However, separation of the major outer membrane proteins of an 
E. coli strain (wild-type K12 described by Henning et al., 
,. 1978) was achieved with ultra-thin (1mm) gradient gels. OmpF 
and OmpC. produced two separate bands and OmpA was also resolved 
(lane a fig 4.8). Polypeptide 3 (c. f. lane e fig 4.6) was 
released by PIBN from this strain and co-migrated with OmpF 
rather than either OmpC or OmpA (lane b fig 4.8). The 
possibility therefore remains that some of the proteins 
released by PMBN, and in particular polypeptide 3, may 
represent OmpF (fig 4.8). Thus various experiments were 
conducted to establish whether or not polypeptide 3 is an outer 
membrane protein. 
4.4 CONFIRMATION OF THE PERIPLASMIC NATURE OF THE 
PROTEINS RELEASED BY PMBN 
The results presented in this chapter so far suggest that PMBN 
exclusively releases periplasmic proteins from E. coli. This 
presumably results from outer membrane damage yet no evidence 
for release of outer membrane proteins has been obtained. The 
contention that no outer membrane proteins were released was 
examined by further separate experiments which aimed to show 






Fig 4.8 Comparison of polypeptides released by PMBN and the 
major outer membrane proteins of E. coli. The profile of 
outer membrane proteins prepared from E. coli K12 as described 
in the text is shown in lane a. The polypeptide profile of 
E. coli K12 following treatment with PMBN (200ug/ml) is shown 
in lane b. The major proteins associated with the outer 




4.4.1 PMBN-released proteins - trypsin digestion: 
The outer membrane protein OmpA (35K) in E. coli is digested 
by the proteolytic enzyme trypsin resulting in two low 
molecular weight fragments of 24K and 19K on MS-PAGE 
(see Chapter 5 and Lugtenberg & Van Alphen, 1983). In order 
partially to characterise polypeptides 3 (36K) and 4 (lane e 
fig 4.6) that were released by PMBN, their tryptic. digest 
products were exämined. Polypeptide 4 was completely digested 
by trypsin (lane b fig 4.9) presumably producing several low 
molecular weight fragments whereas polypeptide 3 was trypsin 
resistant (lane b fig 4.9). 
4.4.2 PMBN released proteins - heat modification: 
Interactions between constituents of the outer membrane are 
very strong and require solubilisation temperatures above 
700C for complete denaturation (Lugtenberg & Van Alphen, 
1983). At temperatures below 700C, incomplete 
solubilisation leads to lowered electrophoretic mobility. 
Indeed, the apparent molecular weight of OmpA after boiling in 
2% SDS is 35K, whereas the molecular weight of the non- 
denatured form is 28K (Lugtenberg & Van Alphen, 1983). The 
migration of the PMBN-released proteins after solubilisation at 
00 60C or 100C was compared, but since no differences 
in their mobilities were observed (fig 4.10), clearly the 
proteins were not heat-modifiable. However, polypeptide 3 may 




Fig 4.9 Cleavage of PMBN-released polypeptides by trypsin. 
PMBN (200ug/ml) released polypeptides 3 and 4 (lane a and see 
also fig 4.6). Cell suspensions of E. coli K12 3300 (pBR322) 
were incubated with trypsin (lmg/mi) for 20 min and the 
reaction terminated by the addition of soybean trypsin 
inhibitor (500ug/ml). The trypsin treated sample was 
lyophilized and subjected to electrophoresis (lane b). 
Proteins were detected by Coomassie blue. The figure shows 
that portion of the gel which contains periplasmic 
polypeptides 3 and 4. The Position of these polypeptides in 
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Fig 4.10 Heat modification of polypeptides released by 
PMBN. Polypeptides 3 and 4 (fig 4.6) were released from 
E. coli K12 3300 (pBR322) following treatment with PMBN. 
Lyophilised protein samples containing proteins 3 and 4 
(arrowed) were solubilized at either 600C (lane a) or 
1000C (lane b) 
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intensity of this band was greater after denaturation of 
samples at the higher temperature (lane b fig 4.10). 
0 
4.4.3- PMBN-released proteins - two-dimensional gel 
electrophoresis: 
Two-dimensional gel electrophoresis is a high resolution method 
for separation of proteins based on both the molecular weight 
and the isoelectric point of the protein (Harnes 1981). 
polypeptides 3 and 4 (lane e fig 4.6) released by, PMBN-were 
resolved as at least 5 separate spots on two-dimensional gels 
(data not shown). The pis of these spots, did not correspond 
either with OmpF (pI 5.0) or OmpC (pI-4.8). 
4.4.4 PNBN-released proteins - characterisation by 
immunoblotting: , 
To examine further whether the proteins released from whole 
bacteria by PMBN. might originate from the outer membrane, the 
proteins were subjected to irrmunoblotting using antisera 
directed against the major outer membrane proteins. 
Preparations obtained after treatment of bacteria with PMBN 
were electrophoresed on the same gel as outer membrane proteins 
prepared by the method of Yamato et al. (1975). The majority 
of polypeptides released by PMBN (lanes b and e fig 4.5) 
transferred. easily to nitrocellulose paper by the method of 
Towbin et (1979). They were then probed with anti- 
OmpF/C serum (kindly provided by Dr. P. Gwen, Trinity College, 
Dublin). The antiserum failed to detect major outer membrane 
proteins in the material released by PMBN (data not shown). 
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Unfortunately, however, the antiserum failed to detect OmpF or 
OrnpC in control outer membrane preparations. 
4.5 POSSIBLE RELEASE OF PROTEIN FROM ISOLATED MEMBRANE 
VESICLES AFTER POLYMYXIN B OR PMBN TREATMENT 
The. possibility that polymyxins might release major proteins 
from isolated outer or inner membrane preparations-was 
examined. Outer and inner membranes were prepared by the 
method of Yamato, et al., (1975) and treated with polymyxin B 
or PMBN for 60 min. Membranes were recovered by centrifugation 
and their polypeptide content examined and compared by 
electrophoresis with similar preparations which had not been 
treated with polymyxins. No evidence for. release of, membrane 




Several of the observations made in this chapter concerning the 
action of polymyxin B and PMBN'are consistent with previously 
published findings. These include the ability of polymyxin B 
to release periplasmic and sane cytoplasmic proteins (Cerny & 
Teuber, 1971 and 1972; Storm et al., 1977 and Vaara & Vaara, 
1981) and the failure of both compounds to release LPS (Cerny & 
Teuber, 1972; Vaara & Vaara,, 1981 and 1983b). However, in 
contrast to the previous studies of Vaara & Vaara'(1983b) I 
have clearly shown that PMBN releases periplasmic proteins. 
Indeed the proteins released by PMBN are likely to be entirely 
derived from the periplasmic space because PMBN failed to cause 
leakage of the` cytoplasmic marker enzyme beta-galactosidase and 
there was no evidence that it released either outer or inner 
membrane proteins from whole cells or isolated membrane 
vesicles. 
As previously mentioned, Vaara & Vaara (1983b) also 
examined the question of whether PMBN releases periplasmic 
proteins. They followed the release of plasmid R471a-encoded 
beta-lactamase from Salmonella typhimurium, but PMBN even at 
concentrations as'high as 100ug/ml apparently failed to release 
the enzyme (Vaara & Vaara, 1983b). However, the experimental 
system adopted in the present study to test for pMBN-induced 
beta-lactamase leakage is undoubtedly more sensitive than that 
employed by Vaara & Vaara. There are two principal reasons for, 
the increased sensitivity of the system adopted in the present 
I 
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study. Firstly, the use of pBR322 rather than R471a to encode 
beta-lactamase provides a higher level of periplasmic enzyme 
because the copy number of pBR322 (20 to 30 per cell) (Boyer 
et al., 1977) is considerably higher than that of R471a, 
which is a large'self-transmissible plasmid likely to be 
present at only a few copies per cell (Hedges et al., 1975 
and Bukhari et al., 1977). Secondly, the beta-lactamase 
assay adopted in the present study uses the chromogenic 
cephalosporin, nitrocefin, whereas Vaara & Vaara used an 
iodometric assay for the enzyme (Vaara & Vaara, 1983b). The 
nitrocefin method is more sensitive than the iodometric system 
(O'Callaghan et al., 1972; Richmond & Sykes, -1973; -Ross & 
O'Callaghan, 1975 and Plested, 1983). 
Apart from the finding that PMBN releases periplasmic 
proteins from Gram-negative bacteria, another observation of 
interest concerns the difference in the ability of polymyxin B 
and PMBN to release a protein of molecular weight 36K from 
E. coli. Although no evidence for release of outer membrane 
proteins had been obtained, it was previously thought possible 
that polypeptide 3 released-fram E. coli following PMBN 
treatment might be one of the major outer membrane proteins, 
because its molecular weight,. (36K) was similar to that of 
the major outer membrane proteins OmpA. OmpF and OmpC 
(Lugtenberg & Van Alphen, 1983). More specifically-it co- 
migrated with the OmpF protein., In support of the possibility 
that this protein is an outer membrane protein, it should be 
noted that osmotic shock procedures can, under certain 
circumstances, liberate proteins from other parts of the cell 
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(Jacobson et al., 1976). The migration of OmpA during 
electrophoresis in the presence of SD6 varies with respect to 
the temperature of denaturation and the protein is also trypsin 
sensitive (Lugtenberg & Van Alphen, 1983). Polypeptide 3 (fig 
4.6) released by PMBN was not digested by trypsin, nor was it 
heat modifiable. Although polypeptide 4 (fig 4.6) was 
trypsin-sensitive it was not heat modifiable. Furthermore the 
trypsin fragments of polypeptide 4 did not correspond to the 
fragments of molecular weights 19K or 24K reported for OmpA. 
These observations discount either polypeptide 3 or 4 as OmpA. 
The 36K protein (polypeptide 3) released by PMBN was 
neither OmpF nor OmpC because its isoelectric point during two 
dimensional electrophoresis differed from OmpF (pI-5.0) and 
OmpC (PI-4.8) outer membrane proteins (Lugtenberg & Van Aiphen, 
1983). Zwo dimensional gel electrophoresis poses difficulties 
for the identification of OmpA, because the protein appears as 
at least twelve spots, most of which are caused by artefacts 
(Henning et al., 1978). Hence conclusive evidence that 
polypeptides 3 or 4 were or were not OmpA could not be obtained 
by this method. Transfer of the proteins released by PMBN onto 
nitrocellulose paper and probed with anti-serum purported to be 
specific for OmpF/C (Dr. P. Owen, personal communication) failed 
to provide conclusive evidence for the outer membrane origin of 
the PMBN-released proteins. The 36K protein preferentially 
released by. PMBN is therefore very likely to be periplasmic 
although its identity as yet is unknown. 
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CHAPTER 5 
FURTHER STUDIES OF THE EFFECTS OF POLYMYXIN B NONAPEPTIDE AND POLYMYXIN B 
ON THE CELL ENVELOPE 
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INTRODUCTION 
In the previous chapter, the effects of polymyxin B and PMBN on 
cell envelope integrity were compared. - Both compounds caused 
loss of proteins from E. coli K12 3300 (pBR322) although PMBN 
released less protein than did polymyxin B. The individual 
proteins released by either compound were different but were 
derived principally from the periplasm accompanied in the case 
of polymyxin B by a low level of cytoplasmic proteins (see 
Chapter 4). The leakage of periplasmic proteins induced by 
PMBN indicates that it probably causes disruption of the outer 
membrane which results in modification of the barrier functions 
of the envelope. These modifications, following treatment with 
agents known to disturb the structure of the outer membrane, 
are well documented (see Hancock, 1984 and Nikaido & Vaara, 
1985 for reviews). Treatment of Gram-negative bacteria with, 
for example, an appropriate concentration of EDTA increases the 
permeability of the cells to a wide range of antimicrobials, 
lysozyme and other enzymes but nevertheless has no effect on 
viability (see review of Wilkinson, 1975). 
This chapter describes experiments which show that PMBN 
-treated cells are more permeable to certain compounds that are 
normally excluded by the intact outer membrane of the cell. To 
date, studies on the permeability changes mediated by PMBN 
involving increased influx have been restricted to low 
molecular weight hydrophobic antibiotics (see Chapter 3; Vaara 
& vaara, 1983a and c; Nikaido & Vaara, l985'and Vaara et al., 
1985). The experiments described here extend the findings of 
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these workers and provide information on the effects of PMBN 
treatment on the subsequent uptake of the hydrophobic dye 
crystal violet and the enzyme lysozyme. 
The potential ability of PMBN to alter the orientation or 
topographical arrangment of membrane-proteins has also been 
studied, as well as the possibility that PMBN interaction with 
membranes might lead to denaturation of membrane enzymes. E 
coli K12 contains the outer membrane protein OmpA which is 
partially exposed at the surface of the cell. ompA is 
important for maintenance of the structural integrity of the 
outer membrane, but unlike the other major proteins is 
susceptible to the proteolytic enzyme trypsin (Hammond et 
al., 1984). N-terminal parts of the'protein however, appear 
to be embedded in the outer membrane since they remain intact 
following trypsin treatment in vivo, whereas isolated OmpA is 
completely digested. Thus, the trypsin cleavage site when OmpA 
is membrane bound is located outside the cell (fig 5.1). The 
complete amino acid sequence of the OmpA protein has now been 
determined (Chen et al., 1980) and the domains associated 
with the outer membrane have been identified. The ability of 
P4BN to alter the accessibility of OmpA protein to trypsin has 
been considered in this chapter. Beta-lactam antibiotics bind 
covalently to membrane located target enzymes, the penicillin 
binding proteins (PBPs), an association that leads ultimately 
to bacterial death (Gale et al., 1981). The PBPs contribute 
to the normal enzymic activities necessary to maintain cell 
integrity, growth and shape. In E. coli, benzyl penicillin 
binds to at least seven different PBPs located in the 
Fig 5.1 Hypothetical structure of the Gram-negative 
cell envelope. The possible disruption caused by the 
intercalation of PMBN and its effects on the 
accessibility of OmpA to trypsin (see text). 
Abbreviations: - 
a= OmpA with trypsin cleavage site. 
t= trypsin. 
lps = lipopolysaccharide. 
pl = phospholipid. 
p= periplasmic protein. 
pg = peptidoglycan. 
bl = bound lipoprotein. 
fl = free lipoprotein. 
an = outer membrane. 
cm = cytoplasmic membrane. 
pn = PMBN. 
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cytoplasmic membrane (fig 5.2). The potential ability of PMBN 
to interfere with the affinity of benzyl penicillin for the 
membrane-located PBPs has been studied. PMBN might affect this 
interaction either a) by altering the topography of the 
membrane and changing the accessibility of PBPs for the 
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ELý 5.2 Properties of the penicillin binding proteins (PBPs) 
of E. coli K12 
(data from Spratt 1977). 
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RESULTS 
5.1 PMBN ENHANCES CELL ENVELOPE PERMEABILITY TO LYSOZYME 
Lysozyme is a protein of molecular weight 14K which acts 
antibacterially by cleaving the sugar backbone of peptidoglycan 
in the bacterial cell wall. It is effective against 
Gram-positive organisms but fails to inhibit Gram- negative 
bacteria because lysozyme cannot normally penetrate their outer 
membranes. Exposure to EDTA destabilises the outer membrane 
sufficiently to allow lysozyme to enter and after peptidoglycan 
degradation cell lysis occurs (DiRienzo et al., 1978 and 
Leive, 1974). To establish whether PMBN also has this 
destabilising property, a direct comparison of the effects of 
EDTA and PMBN on lysozyme-mediated cell lysis was undertaken. 
Concentrated suspensions of E. coli K12 3300 (pBR322) 
(1010 bacteria per ml) were exposed to freshly prepared 
I solutions of lysozyme (0.4ug/ml). Either PMBN (200ug/ml) or 
EDTA (0.3mM final concentration) was then added, the cells 
diluted and absorbance at a wavelength of 675nm determined at 
frequent intervals following addition of the compounds. 
Addition of EDTA caused lysis of the lysozyme-treated cells 
which was reflected by a rapid and sustained fall in absorbance 
values over 50 min (fig 5.3). PMBN treatment also resulted in 
lysis of the lysozyme-treated cells over the time period, 
although the effect was less pronounced than with EDTA (fig 
5.3). Clearly, in comparison with control cells, treatment 















0 10 20.30 40 
Time Cm) 
50 60 
F 5,3 The effects of P. MBN on lysozyme-treated E. coli 
K12 3300 (pBR322). Absorbance values of cell suspensions 
previously exposed to lysozyme ({]) control cells. Treatment 
at time zero with EDTA (0.3mM) (0) or PMN (200ug/ml) (f). 
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cells, (fig 5.3) thus confirming that PMBN promotes lysozyme 
entry to the peptidoglycan. 
5.2 PMBN ENHANCES ENVELOPE PERMEABILITY TO THE 
HYDROPHOBIC DYE-CRYSTAL VIOLET 
The hydrophobic dye crystal violet (molecular weight 408) 
cannot normally penetrate the outer membrane of Gram-negative 
cells (Gustafsson et al., 1973 and Hancock, 1984). However, 
pre-treatment with agents capable of disturbing the barrier 
function of the outer membrane permits the uptake of crystal 
(or gentian) violet (Newton, 1954; Gustafsson et al., 1973; 
Vaara & Vaara, 1981 and Hancock, 1984). 
The uptake of crystal violet was followed. in E. coli K12 
3300 (pBR322). Organisms at the mid-logarithmic stage of 
growth were incubated with lOug/ml of crystal violet at 
370C. for exactly 30 min. The dye remaining in the 
cell-free supernatant was assayed spectrophotometrically at 
590nm according to the method of Gustafsson et al., 1973). 
Untreated control cells bound little crystal violet with the 
result that the majority of the dye remained in the 
supernatant. However, the uptake of crystal violet by bacteria 
treated with either EDTA or polymyxin B was increased, - 
resulting in a lower concentration of dye in the cell-free 
supernatant. Pre-treatment with polymyxin B (200ug/ml) induced 
a 58% uptake of the added dye, whilst EDTA (1mM) treatment 
resulted in only a 31% uptake (table 5.1). Pre-treatment of the 
cells with PMBN also caused an increase in the uptake of 
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TABLE 5.1 
THE EFFECTS OF PMBN AND POLYMYXIN B ON THE PERMEABILITY OF 
E. COLI K12 3300 (pBR322) TO CRYSTAL VIOLET 
TIME ABSORBANCE UPTAKE 
(m) (590nm) ($) 
CONTROL UNTREATED 0 1.66 -- 
CONTROL UNTREATED 30 1.38 17 
POLYMYXIN B (200ug/ml) 30 0.49 58 
EDTA (IM) 30 1.14 31 
PMBN (200ug/ml) 30 0.62 63 
Organisms at the mid-logarithmic stage of growth were 
incubated at 370c with lOug/ml of crystal violet for exactly 




crystal violet by E. coli. - After 30 min at 370c. 63% of 
the dye was taken up by the PMBN-treated cells, compared with 
only 17% uptake by the untreated control (table 5.1). 
5.3 THE EFFECTS OF PMBN ON TRYPSIN DIGESTION OF OUTER 
MEMBRANE PROTEINS 
The proteolytic enzyme trypsin although partially excluded fron 
the cell due to its size nevertheless has the ability to 
release certain outer membrane proteins. To establish whether 
PMBN interferes with trypsin-promoted cleavage of major outer 
membrane proteins in whole cells, bacteria were exposed to 
trypsin, following PNBN treatment and membrane fractions from 
the cell isolated. 
E. coli K12 3300 (pBR322) (1010 bacteria/ml) was 
incubated with trypsin (lmg/ml) following pre-treatment with 
200ug/ml of PMBN for lhr at 370C. Envelope fractions were 
then prepared from these cells by conventional procedures (see 
Chapter 2). Outer membrane proteins from samples were 
separated on SDS-PAGE and the gels scanned to produce 
densitometer traces (fig 5.4). The electrophoretic mobilities 
of OmpF/C and OmpA (fig 5.4A) were consistent with previously 
published work (Chopra & Eccles, 1978). In contrast, 
polypeptide profiles from the outer membrane of cells which had 
been treated with trypsin (fig 5.4B) clearly showed the absence 
of OmpA and the appearance of its low molecular weight 
degradation product which has been described previously 
















Fig 5.4 The effects of PMBN on trypsin digestion of outer 
membrane proteins. Densitometer scans of outer membrane 
proteins fran isolated envelopes (A ); treated with trypsin 
alone (B) or P1BN (200ug/ml) and trypsin (C ). - For details 
of experiment see text. 
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bacteria with PMBN did not alter the ability of trypsin to 
degrade CmpA protein (fig 5.4C). 
5.4 EFFECTS OF PMBN ON AFFINITY OF BENZYL PENICILLIN FOR 
PENICILLIN BINDING PROTEINS (PBPs) IN ISOLATED MEMBRANES 
Benzyl penicillin binds to penicillin binding proteins (PBPs) 
located in the cytoplasmic membrane of all penicillin- 
susceptible bacteria. The PBPs represent the targets of 
beta-lactam-induced killing of bacteria (Gale et al.,, 1981). 
To establish whether PMBN interferes with the affinity of 
penicillin for these proteins, envelope fractions from E. coli 
K12 3300 were isolated and treated'in vitro with 200ug/ml of 
PMBN. Proteins from samples which had been treated with PMBN 
were exposed to 
14C-labelled benzyl penicillin and 
subjected to SDS-PAGE followed by autoradiography (see Chapter 
2 for details). Densitometer scans of the negatives (fig 5.5) 
showed at least 7 major peaks representing those PBPs 
previously identified in E. coli K12 strains (Spratt, 1977). 
However, some degradation during the course of the experiments 
appeared to have produced additional minor peaks in both scans. 
Nevertheless there were no qualitative or quantitative 
differences between PMBN-treated and untreated membrane 
preparations. 
Fig 5.5 Densitometer scans of the penicillin 
binding proteins (PBPs) of E. coli. Envelope fractions 
from E. coli K12 3300 were isolated and treated in 
vitro with 200ug/ml of PMBN as described in Chapter 2. 
Peaks (la - 6) representing PBPs following treatment 
with PMBN are shown in (a). Untreated control PBPs 
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DISCUSSION 
Results presented here indicate that both PMBN and EDTA 
increase the permeability of the E. coli outer membrane to 
lysozyme (fig 5.3). The outer membrane. disrupting action of 
PMBN appears to be similar to polymyxin B in this respect. The 
bactericidal agent polymyxin B allows access of lysozyme 
(Teuber, 1970 and Vaara & Vaara, 1981), although the membrane 
disorganising effects of this agent are generally masked by its 
direct lethal action (Vaara & Vaara, 1983a). 
There are various chemical treatments which can alter the 
penetration barrier of'Gram-negative organisms sufficiently to 
allow them to become susceptible to a range of hydrophobic 
agents to which they were previously insensitive. For example, 
in EDTA-treated cells the barrier function of the outer 
membrane becomes impaired. Leive et al., (1968, and 1974) 
reported that treatment with low levels of Tris-EDTA resulted 
in cells which released up to 50% of their LPS and some 
protein. These cells retained viability but became vulnerable 
to hydrophobic agents such as actinomycin D, novobiocirn and 
rifampicin to which they were not previously susceptible. The 
stability of the outer membrane appears to depend upon the 
presence of divalent ions which link adjacent LPS molecules. 
Removal of these ions by EDTA chelation results in membrane 
disruption. The ensuing loss of LPS apparently leads to the 
breakdown of the penetration barrier and results in an increase 
in the permeability of the cell tö hydrophobic agents and 
detergents. When cells were exposed to lysozyme, EDTA (0.3mM) 
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induced a similar degree of lysis as PMBN (fig 5.3), although 
the mode of action of the two agents appears to be different. 
Unlike EDTA, the outer membrane disrupting action of PMBN (or 
polymyxin B) is not associated with the release of LPS from 
E. coli (see Chapter 4 and Vaara & Vaara, 1983b). 
Normally the basic hydrophobic dye crystal violet does not 
easily penetrate the intact outer membrane, but is able to do 
so without difficulty when the bacteria are damaged by agents 
such as EDTA or polymyxin B (Vaara & Vaara, 1981). Treatment 
of E. coli with either of these agents or PMBN resulted in 
enhanced permeability of the cells to crystal violet (table 
5.1). EDTA at a concentration of 1mM promoted crystal violet 
uptake (31%), whereas values for the uptake by untreated 
(control) cells (17%) were consistent with reports by 
Gustafsson et al., (1973) and Vaara & Vaara, (1981), binding 
being ascribed to adsorption-(but not penetration) of the dye 
to the bacterial cell surface. Treatment of cells with 
polymyxin B resulted in crystal violet uptake (50%; table 5.1) 
consistent with the findings of others (Vaara & Vaara, 1981) 
that polymyxin B disrupts the outer membrane to allow access of 
hydrophobic agents. PNBN when tested at a concentration 
(200ug/ml) equivalent to polymyxin B promoted slightly more 
uptake (63%). The extent of outer membrane disturbance caused 
by pMBN may well account for the rapid sensitisation of 
pMBN-treated cells to hydrophobic antibiotics (see Chapter 3 
and Vaara & Vaara, 1983b). 
The potential ability of PMBN to alter the orientation of 
a major outer membrane protein was investigated. It would seem 
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plausible that perturbation of the cell envelope by the 
intercalation of PMBN might change the orientation of OmpA 
protein. This could allow the exposed cleavage site to become 
inaccessible to trypsin (fig 5.1) or alternatively expose 
digestion sites previously buried in the outer membrane 
bilayer. The OmpA protein of E. coli has been well studied 
(see introduction to this chapter) and its cleavage by trypsin 
established. However, results presented in this chapter 
demonstrated (fig 5.4) that treatment of bacteria with PMBN did 
not alter the pattern of OmpA trypsin degradation products. 
The ability of PMBN to interfere with the affinity of 
benzyl penicillin for PBPs was also investigated. The results 
(fig 5.5) demonstrated' that PMBN did not affect the 
accessibility of PBPs for benzyl penicillin. In addition, PMBN 
did not denature the binding proteins. 
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CHAPTER 6 
ALTERATION OF CYTOPLASMIC MEMBRANE PERMEABILITY INDUCED BY 
POLYMYXIN B NONAPEPTIDE AND POLYMYXIN B 
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INTRODUCTION 
The previous chapter compared the effects of PMBN, polymyxin B 
and EDTA on the permeability of E. coli to various probes. 
Increased permeability of the cells to the dye crystal violet 
and lysozyme, to which they were normally impermeable, resulted 
from treatment with the polymyxins or EDTA. Outer membrane 
perturbation appeared to be responsible for this increase in 
permeability, although the exact mechanism(s) of such 
modification is not known at the present time. 
Polymyxin B disrupts both outer and inner membranes in 
Gram-negative cells (see previous chapters; Newton, 1956; Cerny 
& Teuber, 1971,1972; Storm et al., 1977; Klemperer et al., 
1979 and Gale et al., 1981) and its mode of action is 
undoubtedly related to its membrane damaging effects (Storm et 
al., 1977 and Gale et al., 1981). However, whether damage 
to the outer membrane is more critical for cell killing than 
damage to the cytoplasmic (inner) membrane has not yet been 
clearly established. 
outer membrane disruption resulting from polymyxin B 
treatment is similar to that produced by its deacylated 
derivative PMBN, i. e. both compounds cause leakage of 
periplasmic proteins. Since PMBN has very low intrinsic 
antibacterial activity (see Chapter 3 and Nikaido and Vaara, 
1985) outer membrane damage is unlikely to be directly 
responsible for the bactericidal action of polymyxin B. 
Therefore, the lethality of polymyxin B for Gram-negative 
organisms appears to be the consequence of cytoplasmic membrane 
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disruption. To test this hypothesis further, experiments were 
performed to compare the ability of polymyxin B and PMBN to 
damage the cytoplasmic membrane of E. coli. This chapter 
describes these experiments. The work was approached from the 
following viewpoint: If the lethal effect of polymyxin B arises 
from cytoplasmic membrane damage then it should cause 
significant changes in the permeability of that membrane, 
whereas the non-lethal compound PMBN is predicted to have no 
major effect on it. 
As a general approach, changes in cytoplasmic membrane 
permeability resulting from damage by membrane-active agents 
can be studied by detecting the leakage of small molecules from 
the cell. These molecules, for example amino acids, are 
normally retained in their free state by washed suspensions of 
cells and have been released from this 'pool' in response to 
treatment by, for example, the polymyxins (Newton, 1956) or 
chlorhexidine (Hugo, 1967). In the present study, the effects 
of polymyxin B and 
PMBN 
on the retention of 'pools' were 
studied. In addition, another effect that reflects changes in 
membrane integrity is efflux of potassium ion (K+) from 
cells. This leakage can be monitored by the use of a specific 
potassium ion electrode (Lannigan & Bryan, 1985). The release 
of K+ from polymyxin B and PMBN-treated cells was 
examined. Furthermore, in some of the experiments to be 
described in this chapter the bactericidal agent chlorhexidine 
was used for reference (control) purposes, since it is known to 




6.1 EFFECTS OF POLYMYXIN B AND PMBN ON GROWTH AND 
VIABILITY OF E. COLI 
PMBN had a very low intrinsic antibacterial activity and was at 
least 300-fold less active than polymyxin B (see Chapter 3). 
Viability determinations following exposure to polymyxin B or 
PMBN were performed on E. coli K12 3300 (pBR322)suspended at 
1010 cells per ml in'10mM sodium phosphate buffer (pH. 7.4) 
These conditions are identical to those employed for the 
studies on cytoplasmic membrane damage' (see below) and 
also 
relate exactly to the previous work on protein release from 
this strain, mediated by polymyxin B andPMBN (see chapter 4). 
As already noted exposure to polymyxin B (200ug/ml)'led to 
rapid loss of E. coli viability but an equivalent 
concentration of PMBN had no killing effect (see fig 3.7 which 
is also reproduced here as fig'6.1) 
6.2 LOSS OF AMID ACIDS, URACIL AND K+ FROM 
POLYMYXIN B AND PMBN-TREATED BACTERIA. 
As already noted in the introduction to this chapter, it is 
well established that bacterial cytoplasmic membrane damage can 
be monitored by determining the loss of small (soluble) 
molecules and/or K+ from cells. 
Fig 6.1 Viability of E. coli K12 3300 (pBR322) after 
exposure to polymyxin B or PMBN. Bacteria were grown 
to the mid logarithmic phase, harvested by 
centrifugation, washed in 10mM sodium phosphate buffer 
(pH 7.4) and then suspended in the same buffer to a 
density of 1010/ml. The cell suspension was divided 
into three samples. At time zero, polymyxin B 
(200ug/ml) was added to one portion (" )" and PMBN 
(200ug/ml) to the second (0). The third sample 
served as an untreated control, ( O ). Bacteria were 
incubated at 370C and samples removed at the times 
indicated. Samples were rapidly diluted and then 
plated onto nutrient agar to determine viable 
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6.2.1 Leakaqe of amino acids 
A mixture of 
3H-labelled 
amino acids was used to produce a 
labelled amino acid pool within E. coli K12 3300 (pBR322). 
Loss of amino acids from this pool was then followed by 
standard procedures (Chapter 2 and Britten & McClure, 1962). 
Approximate rates of radioactive loss were determined fran the 
curves shown in fig 6.2. Untreated bacteria showed a low level 
of amino acid loss which exhibited biphasic kinetics (fig 6.2). 
During the first phase (lasting approximately 20 min) amino 
acid loss was relatively rapid (28 c. p. m. radioactivity 
lost/min), but this was followed by a second phase in which the 
rate of loss was very much slower (2 c. p. m. lost/min) (fig 
6.2). Compared to the controls, polymyxin B (200ug/ml) and 
PMBN (200ug/ml) treatments resulted in enhanced, rates of amino 
acid loss from E. coli (fig 6.2). This was reflected by 
accelerated loss in both the primary and secondary phases of.. 
amino acid leakage. In the primary phase the rate of 
pMBN-promoted loss was 65 c. p. m. /min and in the secondary phase 
11 c. p. m. /min. The rate of amino acid loss promoted by 
polymyxin B in-the primary phase (153 c. p. m. /min) was 
approximately two-fold greater than that caused by PMBN (65 
c. p. m. /min). However the rates of secondary phase loss 
promoted by both compounds were similar (about 11 c. p. m. /min in 
each case), but greater than the rate of loss from untreated 

















Fig _ Release of free (pool) amino acids from E. coli 
K12 
3300 (pin, 322)" Bacteria were grown to mid logarithmic phase 
and then incubated 
for 60 min with chloramphenicol 100ug/ml 
and 
3-H amino acids (2uCi/ml) to form a labelled amino 
acid pool- Bacteria were 
then prepared and exposed to 
polyrnyxin B 
(200ug/ml) ( ") or PMBN 200ug/ml ( 0) as 
described in fig 6.1. A third sample served as an untreated 
control ( 
11 )- Steles were removed at the time indicated and 
processed as 
described in the text. 
08 16 24 32 40 48" 56 64 
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6.2.2 Leakage of uracil 
E. coli K12 3300 (pBR322) was also labelled with 6-3H- 
uracil to follow loss of uracil from the cytoplasmic pool 
(Dougherty & Saukkonen, 1985). The results (fig 6.3) were 
comparable with those obtained for amino acid loss. Control 
(untreated) bacteria showed a low level of loss which displayed 
biphasic kinetics. Polymyxin B (200ug/ml) and PMBN (200ug/ml) 
both considerably increased the rates of loss of uracil from 
E. coli (fig 6.3). The rate of loss in the primary phase 
promoted by polymyxin B was approximately 1.5-fold greater 
than that caused by PMBN (fig 6.3) 
6.2.3 Potassium ion loss 
K+ loss was investigated under conditions comparable to 
those used for amino acid and uracil leakage. Polymyxin B 
(200ug/ml) caused an immediate loss of K+ (fig 6.4) which 
was conplete within the first minute of exposure to the 
antibiotic (fig 6.4). PMBN (200ug/ml) also caused inIInediate 
K+ leakage (fig 6.4). However, the loss of K+ 
promoted by polymyxin B was approximately 2-fold greater than 
that caused by PMBN. Control (untreated) bacteria showed no 
K+ loss (fig 6.4). 
E. coli cells prepared in 10mM sodium phosphate buffer 
(pH 7.4) as detailed above were treated with a concentration of 
chlorhexidine (200ug/ml) equivalent to that already used for 
polymyxin B. Chlorhexidine at 200ug/ml induced an immediate 
leakage of K+ although complete release of K+ was 














Fß. 3 Release of free (pool) uracil fron E. coli K12 3300 
(pBR322). Bacteria were grown to mid logarithmic phase and 
then incubated with 6 
3-H-uracil (2uCi/ml) for 45 min to form a 
labelled uracil pool. Bacteria were then prepared and exposed 
to polymyxin B (200ug/ml) (") or PMBN 200ug/ml ( 0) as 
described in fig 6.1. A third sample served as an untreated 
control ( 11 ). samples were removed at the time indicated and 
processed as described 
in the text. 
08 16 24 32 40 48 56 
Time (m) 














Fiq 6.4 Release of potassium ions from E. coli K12 3300 
(pBR322). Bacteria were grown, prepared and exposed to 
polymyxin B (200ug/ml) ( ") or PMBN (200ug/ml) ( 0) as 
descibed in the text. A third sample served as an untreated 
control (Q). 
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Thus chlorhexidine treatment elicited a response from cells 
similar to that obtained with polymyxin B (fig 6.5). 
Fig 6.5 Release of potassium ions from E. coli K12 
3300 (pBR322). Bacteria were grown, prepared and 
exposed to polymyxin B (200ug/ml) (") or 
chlorhexidine (200ug/ml) (f) as described in the 
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DISCUSSION 
Although the ability of polymyxin B to cause loss of small 
molecules and K+ from Gram-negative bacteria is well 
documented (Storm et al., 1977; Gale et al., 1981 and 
Lannigan & Bryan, 1985), this is the first report that PMBN has 
similar properties. The capacity of both compounds to produce 
these changes probably reflects direct interaction with the 
inner (cytoplasmic) membrane of the cell envelope, because both 
molecules bind to cytoplasmic membranes from Gram- negative 
bacteria (Storm et al., 1977 and Vaara & Viljanen, 1985). 
However, since both compounds produce outer membrane damage 
(Storm et al., 1977; Gale et al., 1981 and Nikaido & Vaara, 
1985); it seems probable that they both promote their own 
access to the inner membrane by first binding to and then 
disrupting the outer membrane. Indeed, this suggestion has 
already been specifically advanced for polymyxin B (Nikaido & 
Vaara, 1985). 
Polymyxin B and PMBN both cause leakage of amino acids, 
uracil and K. 
ý from E. coli. Since PMBN has virtually no 
antibacterial activity, leakage of these cytoplasmic 
constituents cannot in itself be lethal. Others have also 
noted a lack of correlation between leakage of cytoplasmic 
constituents and killing in Gram-negative bacteria. For 
instance, Britten & McClure, (1962) found that osmotic shock 
reduces the amino acid pool of E. coli by about 50% without 
affecting protein synthesis and that other treatments which do 
not result in cell death may nevertheless cause complete pool 
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loss. Both polymyxin B and chlorhexidine at comparable 
concentrations, induce a rapid loss of K+ within the first 
minute of exposure to cells. However, it is unlikely that 
potassium leakage is directly responsible for the killing of 
the cell. Indeed, several authors (Chen et al., 1978 and 
Lannigan & Bryan, 1985) have been unable to establish 
irrefutably that K+ leakage is related to the killing of 
bacteria. Thus rapid loss of small molecules probably reflects 
the permeability changes caused by initial contact between the 
antibiotic and the inner membrane (Lannigan & Bryan, 1985). 
Polymyxin B or PMBN treatment results in loss of proteins 
from E. coli. Those released by PMBN are derived solely from 
the periplasm (see Chapter 4) whereas polymyxin B induces 
release from both the periplasmic region and the cytoplasm 
(Chapter 4 and Cerny & Teuber, 1971,1972). Both polymyxin B 
and PMB1 promote release of. small molecules and K+ from 
the cell (see above). However, the integrity of the 
cytoplasmic membrane is only sufficiently disturbed to release 
proteins from the cytoplasm by polymyxin B. PMBN lacks this 
ability and so, despite measurable effects on the cytoplasmic 
membrane, fails to kill the cell. 
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CHAPTER 7 
ULZRASTRUCZURAL CHANGES OF ESCHERICHIA COLI IN 
RESPONSE TO POLYMYXIN B NONAPEPTIDE OR POLYMYXIN B 
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The previous chapter described the interaction of polymyxin B 
and PMBN with the cytoplasmic (inner) membrane. Both compounds 
disturbed cytoplasmic membrane integrity, reflected by loss of 
free amino acids, uracil and K+ from E. coli, and for 
polymyxin B leakage of cytoplasmic proteins. The polymyxins 
also cause disorganisation of the outer membrane leading to 
loss of periplasmic proteins (see Chapter 4) and concomitant 
changes in the permeability towards hydrophobic agents (see 
chapter 5; Vaara & Vaara, 1983a, b&c and Lam. et al., 1986). 
The disorganisation induced by polymyxins may produce 
morphological changes in the cell envelope detectable by 
microscopy. Vaara & Vaara, (1983b) used transmission electron 
microscopy to examine bacteria for ultrastructural damage 
following PMBN treatment. They demonstrated PMBN-induced thin, 
finger-like projections on the surface of S. typhimurium. 
In the present chapter, the effects of PMBN on the 
ultrastructure of E. coli have been examined in more detail 
than in Vaara & Vaara's studies by using the high resolution 
techniques of both transmission and scanning electron 
microscopy. Both are useful techniques for investigating the 
fine structure of bacterial cells. Scanning electron 
microscopy (SEM) has been used primarily in this study to 
examine the surface topography of bacteria, whereas fine 
structural detail has been provided by transmission electron 
microscopy (TEM). The resolution of TEM is greater than SEM, 
but the images produced are only two-dimensional. Although the 
F 
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magnification obtained with SEM is less than that of TEVI the 
bacteria are viewed as three-dimensional structures. In 
addition, processing of specimens for SEM is less disruptive to 
cells than for TEM (Holt & Beveridge, 1982). 
Since the morphological response of E. coli and other 
Gram-negative cells to polymyxin B has been well documented 
(Wahn et al., 1968; Koike et al., 1969; Schindler & Teuber, 
1975; Lounatmaa et al., 1976 and Storm et al., 1977), the 
structural changes in cells after exposure to PMBN have been 
compared to polymyxin B as a'reference control. 
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RESULTS 
7.1 ELECTRON MICROSCOPY 
7.1.1 Scanning electron microscopy (SEM) 
Cells of E. coli K12 3300 (pBR322) were grown, harvested and 
resuspended to a density of 1010 bacteria per ml of 
phosphate buffer. Bacteria were then treated with PMN or 
polymyxin B_(200ug/ml) for 1 hour and together with untreated 
controls prepared for SEM as described in Chapter 2. Bacteria 
(1010 cells per ml) exposed to either PMBN or polymyxin B 
for 60 min exhibited no gross change in cell shape (fig 7.1a 
and b) compared to controls when examined by SEM (fig 7.1c). 
However, the outer surfaces of cells which had been treated 
with polymyxin B (fig 7.1a) demonstrated a greater degree of 
irregularity than PMBN-treated (fig 7.1b) or untreated 
(control) bacteria (fig 7.1c). No evidence for cell lysis or 
release of particles was noted. 
7.1.2 Transmission electron microscopy (TEM) 
Cells of E. coli K12 3300 (pBR322) were treated with polymyxin 
B or PMBN as above and prepared for TEM as described in Chapter 
2. Preliminary experiments were conducted to define those 
conditions that minimised plasmolysis of cells caused by 
inadequate penetration of fixative (data not shown). This 
allowed the characteristic triple-layered structure of the 
Gram-negative cell envelope to be observed. Exposure of 
bacteria to either polymyxin B or PMBN for 60 min led to 
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a 
Fig 7.1a and b Cells (1010/ml) treated with 200ug/ml 






Fig 7.1c Untreated cells (1010/ml) of E. coli K12 
3300 (pBR322) (magnification x 28,800). 
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distinct morphological changes. Polymyxin B caused the 
appearance of numerous protrusions over the entire surface of 
the cell (figs 7.2 and 7.3). Furthermore polymyxin treatment generally 
caused closer association between cells (e. g. figs 7.2 and 7.3). This 
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effect may be related to the clumping"of. polymyxin-treated 
cells that was observed by phase contrast microscopy4(data not 
shown). The response of cells to PMBN after 60 min, was: 
different, fewer protrusions were observed than with,, polymyxin 
B and these were longer, well-defined, finger-like'projections 




seen with polymyxin B. PMBN-treated cells failed to'exhibit 
the pronounced clumping demonstrated by polymyxin B.;, IIn 
contrast to the effects observed with the polymyxins the cell 
{ER: 
surface of untreated E. coli (fig 7.6) remained undisturbed. 
The results described above relate to samples exposed'to 
polyryxins for 60 min. At early time points following 
treatment (15 min), PMBN induced vesicular structures which 
were , apparently: closely' associated-with. the cell surface"(fig 
7.8) *. In contrast polymyxin B -initially' 
, 
(15 min, sale )',; 
developed small folds on the surface (fig 7.7) which were 
similar to those described by Lounatmaa et al., (1976). Both 
their number and size increased with time. This was consistent 
with the findings of these authors who showed that the response 
of cells to polymyxins depends on a number of factors e. g. the 
concentration of antibiotic and time of exposure. 
The experiments just described employed conditions 
identical to those used in biochemical investigations of PMBN 
and polymyxin B presented in Chapter 4. Specifically, 





Fig 7.2 Cells (10 10/m1) treated with 200ug/ml of polymyxin B 
for 60 min (Magnification approx. X 52,000). 
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treatment of bacteria (1010/ml) with PMBN for 60 min at 
37 0C did not kill the organisms. However, when smaller 
.,. numbers of bacteria (109cells/ml).. were tested'. withlthe 
ýý '' ýf °' same concentration' of ' pMBN ' (200ug/ml) aas previously: employed, 
more severe effects on the morphology of the cells were 
observed. A higher proportion of these cells exhibitedt; nuclear 
dense material and contraction of the cytoplasm (fig 7:, 10), 
indicating cellular death. Polymyxin B-treated cells also 
demonstrated extensive damage when tested at the lower. "cell 
density (fig 7.9). Moreover, when cell numbers were further 
reduced to approximately 106 cells per ml, the structural 
damage caused by both PMBN and polymyxin B was severe enough to 
be clearly seen using SEM (figs 7.11a and b). Exposure. to polymyxin B 
produced extensive protrusions or blebs on the surface öf 
E. coli and some of this particulate material appeared tö be 
e 
released from the cells, together with loss of the general 
structural integrity of the cell (fig 7.11a). The changes 
caused by PMBN were less severe but also appeared toýinvolve 
the formation of large blebs on the cell surface (fig 7. llb). 
In contrast, the untreated E. coli cells (fig 7.116) had a much 
smoother surface than those treated with either polymyxin B or 
PMBN and separate particles were rarely seen. 
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Fig 7.3 Higher magnification of cells from fig 7.2 treated 
with 200ug/ml of polymyxin B for 60 min (Magnification approx. 
X 170,000). 
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7.2 EFFECT OF PMBN ON VIABILITY OF CELL SUSPENSIONS 
CONTAINING LESS THAN 1010/ML BACTERIA 
As seen above, the exposure of a progressively decreasing 
number of cells to a fixed concentration of P[IBN increased the 
degree of cellular damage. This prompted an experiment to 
investigate the viability of PMBN-treated E. coli at lower 
bacterial numbers than previously employed. This showed that 
200ug/ml'of PMBN, which had consistently failed to kill cells 
at concentrations of 1010/ml, exhibited considerable 
potency against smaller cell numbers. At 109 cells per 
ml, PMBN killed 95% of the culture and this was further 
reflected by a general increase in P14BN potency at lower cell 
densities (data not shown). The bactericidal effects of PNBN 
on suspensions at 109 cells per ml were consistent with 
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Fig 7.4 Cells (1010/ml) treated with 200ug/ml of PMBN for 60 
min (Magnification approx. x 84,500). 
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Fig 7.5 Higher magnification of cells from fig 7.4 treated 








Fig 7.6 Untreated cells 10 10 /ml of E. coli K12 3300 
(pBR322) (Magnification approx. x 52,000). 
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Fig 7.7 Detail of ultrastructure of cells treated with 












Fig 7.8 Detail of Ultrastructure 
of cells treated with 




Fig 7 .9 Cells 
(109/ml) treated with 200ug/ml of polymyxin B 
for 60 min (Magnification approx. x 52,000). Note brightening of 
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gig 7.10 Cells (10 9/ml) treated with 200ug/ml of PMBN 





Fig 7.1ia and b Cells (approx 106/ml) treated with 
200ug/m1 of a) polymyxin B or b) PMBN for 60 min 
('acnification x 14,400). Note particulate material. 
Fia 7. llc entreated cells (approx 10 6/ml) of E. coli 
K12 3300 (pBR322) (Magnification x 14,400). 
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DISCUSSION 
This chapter has described the morphological responses of 
E. coli to the polymyxins. Experiments were designed to 
duplicate the conditions previously employed to investigate the 
biochemical effects of the polymyxins (see Chapters 3- 6). 
Under conditions which had promoted the leakage of periplasmic 
proteins and soluble cytoplasmic components, both polymyxin B 
and PMBN caused distinct morphological changes in the outer 
layers of E. coli. It would seem likely therefore, that the 
observed morphological disruption of the outer membrane 
accounts directly for the loss of periplasmic proteins. The 
image of the cytoplasmic membrane however is not easily 
visualised by either SEM or TEM. Nevertheless, no gross 
morphological alterations were observed despite biochemical 
evidence that the inner membrane was perturbed. 
The findings presented here for polymyxin B are in general 
agreement with earlier work concerning the effects of 
polymyxins on the ultrastructure of Gram-negative cells 
(Chapman, 1962; Suganuma et al., 1968; Wahn et al., 1968; 
Koike et al., 1969; Koike & lida, 1971 and Lounatmaa et 
al., 1976). The responses to polymyxin B of the E. coli 
strain used here and a strain of S. typhimurium described by 
Lounatmaa et al., (1976) were remarkably similar. Viewed by 
TEM, both organisms produced small wide flat projections 
following treatment with polymyxin B. 
The projections induced by polymyxin B clearly involve 
degradation of the cell envelope outer membrane. They appear 
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to be extensions of this structure, which nevertheless remains 
continuous throughout. Lounatmaa et al., (1976) have studied 
the protrusions produced by polymyxin B in S. typhimurium. 
Since they had no distinct morphology, it was concluded that 
these projections might simply be lipid micelles, perhaps 
representing LPS and other outer membrane components. In 
contrast to polymyxin B. PMBN promoted long finger-like, but 
less numerous, projections on the surface of E. coli 
consistent with the response of S. typhimurium to PMBN 
previously described by Vaara & Vaara, (1983b). 
The separate morphological responses produced by these 
compounds probably reflects the difference in their structures, 
which in turn results in different modes of binding to the 
envelope. Polymyxin B intercalates with the LPS causing 
massive expansion of the surface area and forcing the membrane 
into numerous folds (Lounatmaa et al., 1976). PMBN shares 
the same binding site (acidic LPS) but has a lower affinity for 
it than polymyxin B (Vaara & Viljanen, 1985). The higher 
affinity of polymyxin B must be due to its fatty acid component 
which is thought to interact hydrophobically with the lipid A 
of the LPS (Vaara & Viljanen, 1985). In addition, the 
different structural changes observed after polymyxin B and 
PMBN treatment could reflect the different effects of the 
compounds on general cell metabolism. Metabolic processes 
stop rapidly as a result of the lethal effects of polymyxin B, 
whereas limited metabolism, in PMBN-treated cells, might 
continue in phosphate buffer thus allowing further cell surface 
extension. 
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Release of particulate material was only observed under 
the electron microscope when low numbers of cells were exposed 
to polymyxin B or to PMBN (figs 7. lla & b). Studies with the 
polymyxin analogue, EM49 show that this agent is capable of 
releasing particles from E. coli, identified as outer membrane 
fragments (Rosenthal et al., 1976). However there is no 
biochemical evidence from this study or that of other workers 
(Cerny & Teuber, 1972; Storm et al., 1977; and Vaara & Vaara, 
1981,1983b) that polymyxin B or PMBN actually release outer 
membrane material from Gram-negative bacteria. 
Finally, the observation that exposure of a decreasing 
number of cells to a fixed concentration of PMBN or polymyxin B 
increases the degree of cellular damage is interesting. It 
suggests that polymyxin B or PNBN cause less extensive 
disruption to large numbers of cells because their high surface 






This thesis has presented microbiological, biochemical and 
morphological studies on the mode of action of polymyxin B and 
its derivative PMBN. A further aspect of the studies has been 
to reveal details of the molecular organisation of the 
Gram-negative bacterial cell envelope. 
The investigations presented here have confirmed that 
removal-of the N-terminal diaminobutyric acid residue with - 
attached fatty acid, from polymyxin B, produces a derivative 
(PMBN) with poor antibacterial activity compared to the parent 
compound (Chapter 3). Furthermore, it was also confirmed that 
PMBN sensitizes E. coli to a number of hydrophobic antibiotics 
(Chapter 3). Investigations of this phenomenum by Vaara & 
Vaara (1983a and c) suggested that sensitization of 
Gram-negative, bacteria by PMBN occurred at the level of the 
cell envelope. This prompted them to study a number of 
biochemical factors that indicate membrane disruption. Their 
results showed that although PMBN could be classified as an 
agent capable of interacting with the outer membrane (Vaara & 
Viljanen, 1985),. it did not provoke the major disruption of 
membrane integrity associated with polymyxin B. The results 
presented in this thesis confirm the ability of polymyxin B to 
release both periplasmic and cytoplasmic proteins from cells. 
This is a clear indication that disruption of both outer and 
inner membrane integrity has occurred (Chapter 4 and Cerny &" 
Teuber, -1971 and 2). However, despite reports by Vaara & Vaara 
that Pt N modifies the permeability of the outer membrane and 
even causes ultrastructural damage, these workers were unable 
to demonstrate leakage of proteins from treated cells. In 
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contrast however, the results in Chapter 4 have clearly shown 
that PMBN releases periplasmic proteins. 
Agents able to disrupt the integrity of Gram-negative 
outer membranes can be classified into two general groups: i) 
those that release periplasmic proteins and rapidly sensitize 
cells to hydrophobic antimicrobial agents, and ii) those that 
do not cause periplasmic leakage and'lead only to slow 
sensitization to hydrophobic antibiotics (Nikaido & Vaara 
1985). PMBN exerts a rapid sensitizing action and would 
therefore appear to fall into the first group. Its apparent 
inability to release periplasmic proteins previously precluded 
this classification, but the data presented in Chapter 4 
resolves the dilemma; i. e. PMBN, like other compounds which 
cause rapid sensitization to hydrophobic antibiotics, releases 
periplasmic proteins.. 
It is paradoxical that although polymyxin B and PMBN have 
strong affinities for the outer membrane (Vaara & Viljanen, 
. 
1985) and affect its integrity, there are no reports of the 
release of proteins or other components from the outer membrane 
following treatment (Cerny & Teuber, 1972; Storm et al., 1977 
and Vaara & Vaara, 1981 and 1983a, b& c). This study has 
established that proteins released by PNIDN were derived 
exclusively from the periplasm. PNBN released less protein 
" than polymyxin g although the individual proteins released, 
differed. The release of different proteins from the 
periplasmic region of the cell suggests that polymyxin B and 
Pt N act. differently on the cell envelope. This may be due to 
the-nature of the interaction between polymyxin B or`PMBN and 
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the LPS of the outer membrane. Vaara & Viljanen (1985) 
reported competition data to show that polymyxin B has a higher 
affinity for the acidic LPS binding site than PMBN. The 
binding affinities of the compounds for this site are probably 
reflections of differences in their chemical structure. The 
higher affinity of polymyxin B is probably due to its fatty 
acid component, which is thought to interact hydrophobically 
with lipid A of LPS (Vaara & Viljanen, 1985). Therefore, the 
release of different proteins by the two polymyxins could be 
due indirectly to the different modes of binding of the 
compounds to LPS. These effects may induce topographical 
changes-in the organisation of the outer membrane allowing the 
release of specific periplasmic proteins. 
Another important observation relating to the binding of 
polymyxins to LPS is their ability to displace magnesium ions 
from surface sites such as phosphate on LPS (Nicas & Hancock, 
1980 and Hancock, 1981). Polycationic compounds such as the 
polymyxins attack the divalent cross-bridges between LPS 
molecules. Competition by polymyxin B for cation binding sites 
displaces magnesium ions and increases the permeability of the 
outer membrane with concomitant loss of periplasmic proteins 
(Cerny & Teuber, 1971). The permeability changes noted with 
EDTA (Chapter 5) also appear to be due to disturbances of the 
same site. However, EDTA is a strong chelating agent and 
therefore the mechanism which leads ultimately to permeability 
changes, appears to be chelation rather than competition for 
the. site. The lytic effects of polymyxin B can be inhibited by 
high concentrations of competing cations (Newton, 1953) and 
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studies by Brown (1975) and Nicas & Hancock (1980) have 
supported the contention that competition for the cation 
binding site in the core region of the. LPS, is an important 
factor in-polymyxin activity. Although Storm et al. (1977) 
have suggested that polymyxin B might bind relatively 
non-selectively to both KDO and phosphate groups of the LPS, 
the detailed work of Schindler & Osborn (1979) with 
S. typhimurium LPS has demonstrated novel high affinity 
divalent cation binding sites. These sites appear to be formed 
by the three highly negative KDO residues of the LPS molecule 
(see Chapter 1) and are possibly the molecular site of 
competition between divalent cations and polymyxin B in the 
outer-membrane. A report that binding of PMBN to LPS can also 
be inhibited by high concentrations of competing divalent 
cations (Vaara & Viljanen, 1985) supports the contention of a 
common binding site on the outer membrane for both polymyxin B 
and PMBN. Recent studies by Peterson et al. (1985) have 
investigated the ability of polymyxin B and PMBN to alter the 
packing arrangement of bacterial LPS. Using electron spin 
resonance techniques (Coughlin et al., 1981) the ability of 
polycations-to displace the cationic spin probe (CAT12) 
from P. aeruginosa LPS was assessed. Binding of either PMBN 
or-polymyxin B to the anionic groups on the LPS altered the 
conformation of LPS aggregate structure apparently by 
disrupting LPS-LPS interactions. However, although both 
compounds appear to bind to the same site on the outer 
membrane, their subsequent effects in terms of the release of 
individual proteins, as well as on the viability of the cell as 
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shown in this thesis, are different. 
The release of different proteins from the periplasm has 
been a feature of the studies presented here and may suggest 
that polymyxin B and PMBN promote polypeptide release from 
specific compartments in the periplasm. This suggestion would 
depend on a more ordered arrangement-and compartmentalisation 
of proteins in the periplasm than previously considered (see 
Chapter 1 and Costerton et al., 1974). However, recent 
investigations into the organisation of the. periplasm by Hobot 
et al. (1984) and Brass et al. (1986) have led to a 
reconsideration of the nature of the 'periplasmic space'. 
These workers present data suggesting that the periplasm is 
extremely viscous and might in fact consist of a gel. Brass 
et al. (1986) concluded that the periplasm is a single 
contiguous- compartment surrounding the cell. However, their 
data is consistent with a model that the periplasm may be 
divided into many small but connected compartments, with 
barriers restricting the area through which diffusion from 
compartment to compartment could occur. The release of 
different proteins from the periplasm described in this thesis 
is consistent with the model presented above although no 
electron microscopic evidence at present exists to suggest 
compartmentalisation of the periplasm (Brass et al., 1986). 
Apart from binding to the outer membrane, it is clear from 
data presented in this thesis that both polymyxin B and PMBN 
are likely to interact directly with the cytoplasmic membrane. 
For instance, the data in Chapter 6 show that both polymyxin B 
and PMBN cause leakage of small molecules and potassium ions 
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from Gram-negative cells. The degree of damage measured by 
these markers probably reflects the binding of the compounds to 
the cytoplasmic membrane (Storm et al., 1977 and Vaara & 
Viljanen, 1985). {` The disruptive effects of polymyxin B were 
severe enough to allow the release of large proteins 
(beta-galactosidase) from the cytoplasm (Chapter 4; Cerny & 
Teuber, 1971 and Vaara & Vaara, 1981). The bactericidal 
properties of polymyxin B however, are likely to be related to 
other aspects of cytoplasmic membrane function that were not 
examined (see later). 
As mentioned above and in Chapter 1, the molecular basis 
of polymyxin B action is poorly understood and probably 
involves a number of simultaneous effects on the cell. At the 
molecular level a number of studies have suggested that 
polymyxin B, being an amphipathic molecule, destabilises 
bilayers by interacting with both the polar and non-polar 
regions of lipids (Teuber & Bader, 1976). However, recent 
studies with model membrane systems (Theretz et al., 1984) 
have produced two suggestions on how polymyxin B might interact 
with bilayers. First that polymyxin B is adsorbed at the 
surface of the lipid layer with only its hydrophobic tail 
penetrating between the lipid molecules (Hartmann et al., 
1978 and Sixl & Galla, 1982). Secondly the entire polypeptide 
penetrates deeply into the lipid bilayer (El Mashak & Tocanne, 
1980). The importance of the fatty acid tail of polymyxin B in 
membrane. interactions is indicated in a novel system reported 
by Carr & Morrison (1985). Polymyxin B induced haemolysis of 
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LPS-coated rabbit erythrocytes whereas PMBN had no lytic 
effect. Furthermore these authors showed that PNBN blocked the 
lytic effect of polymyxin B on the erythrocytes and suggest 
that although PMBN retains the capacity to bind to LPS, the 
presence of the terminal fatty acid of polymyxin B is critical 
for erythrocyte lysis. 
However, despite'. theories concerning the molecular events 
leading'to loss of'cell integrity, it remains clear that 
polymyxin B-promotes leakage of cytoplasmic proteins (Cerny & 
Teuber, 1971). These proteins may play a role in the lytic 
event, as release'of murein hydrolases might explain why 
polymyxin'B-treated cells rapidly lyse (White et al 1949., 
and Tai &-Van'Heyningen, 1951). Bacterial murein hydrolases 
(autolytic enzymes) participate in normal murein'expansion by 
providing space and acceptor sites for new material to be 
condensed into the growing sacculus by murein synthetic enzymes 
(Holtje & Schwarz, 1985). ' Under normal conditions the 
autolytic enzymes are prevented from causing gross digestion of 
the murein that would lead to cell lysis. Control of these 
enzymes to prevent digestion of the cells own murein is 1 
obviously important. The cytoplasmic membrane is one of the 
important factors in providing an anatomical barrier to 
separate peptidoglycan from hydrolytic enzymes (Hartmann et 
al., 1974 and Holtje & Schwarz, 1985). Disruption of the 
normal anatomical barrier by polymyxin B, thereby permitting 
leakage-of autolytic enzymes could possibly account for the 
bactericidal properties of the antibiotic. In E. coli, 
amidase B-N-acetylglucosaminidase and peptidase have been 
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detected (Rogers - et al., 1980) and the amidase has been 
purified. Studies to detect the location and subsequent 
release of murein hydrolases'in the cell envelope following 
polymyxin B treatment would be of interest. 
Evidence for morphological damage to E. coli produced by 
both PMBN and polymyxin B was obtained by electron microscopy. 
Disturbance of the surface morphology of bacteria was 
consistent with the reported effects of a number of other 
membrane-active agents. These included the polycations, 
protamine and polylysine (Nikaido & Vaara, 1985), EDTA (Hancock 
1984) and octapeptin-(Storm et al., 1977). In addition the 
outer surfaces of cells can be made to "bleb" by physical 
treatments. - Examination-of E. coli exposed to reagent grade 
water show outer membrane*blebbing as do cells that are heat 
treated-(Tsuchido et al., 1985). It has also been thought 
that morphological effects seen in electron micrographs of 
cells treated with membrane-active agents might be artefacts of 
fixation and thin sectioning of weakened membranes. However, 
the bacteria described in Chapter 7 were also examined by SEM, 
atechnique that is less destructive to the cell envelope than 
fixation and thin sectioning. Application of this technique, 
together with TEM demonstrated that E. coli treated with 
either polymyxin B or PMBN had numerous blebs on the outermost 
surface, probably as a, result of antibiotic intercalation into 
the membrane surface (see Chapter 7). Since PMBN and polymyxin 
B, both cause disruption of the outer membrane, the fatty acyl 
tail associated with the latter does not appear to be a 
requirement for intercalation with membranes and the ensuing 
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development of protrusions. 
Interestingly, the aminoglycoside antibiotic gentamicin is 
another agent which has recently been reported to-cause 
extensive protrusions on the surface of Gram-negative cells 
(Martin & Beveridge, 1986). These authors have shown by a 
variety of electron microscopy techniques that gentamicin 
induced blebs when P. aeruginosa or E. coli K12 were treated. 
Furthermore, -gentamicin appears to displace divalent cations in 
the outer membrane of the cells in a manner similar to 
polymyxin. B. These authors suggest the initial interaction of 
gentamicin with Gram-negative cells appears to be comparable to 
that of the polymyxins. They were able to follow the 
disruption of the cell envelope caused by gentamicin in 
P. aeruginosa. ' Remarkably they were able to observe small 
transient holeiwithin'the outer membrane and follow the 
disruptive process through from outer to inner membrane. 
Despite the intensive examination by thin-section studies 
described in this study, breaks or holes in the continuity of 
the outer membrane of cells treated with either PMBN or 
polymyxin B were not revealed. Furthermore, it was not 
possible with polymyxin B-treated cells to discern areas of 
degradation of the peptidoglycan or disruption of the inner 
membrane related to antibiotic action. However, in their 
studies (Martin & Beveridge, 1986) showed that gentamicin led 
to release of outer membrane proteins and LPS fron the cell. 
In contrast, I was unable to demonstrate loss of outer membrane 
components after polymyxin B or PMBN treatment. 
Since one of the important features of PMBN is to 
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facilitate the penetration of antibiotics into Gram-negative 
bacteria, its possible value in the treatment of infections is 
obvious. Lam et al (1986) were the first to explore the 
extent to which the outer membrane disorganising activity of 
PNIDN could be applied to the treatment of experimental 
infections. These studies have shown that P? BN was ineffective 
against mice infected systemically with E. coli. There was no 
protective effect against experimental septicaemia when PMBN at 
concentrations of up to 200mg/kg body weight was tested alone 
or in combination with an equivalent concentration of 
erythromycin (Lam et al., 1986). This was a disappointing 
finding since PMBN interacts synergistically with erythromycin 
against this strain of E. coli in vitro. 
Finally, in the future, specific areas of interest 
concerning PMBN might be i) its effects on the interaction of " 
bacterial adhesins with their mammalian receptors (see Chapter 
1) and ii) the effects of PMBN on bacterial conjugation. 
Preliminary results from these laboratories show that K88- 
mediated adhesion of E. coli: to guinea pig erythrocytes is 
significantly reduced by PMBN. Whether PMBN acts by directly 
affecting the integrity of the K88 pili or by other membrane 
related mechanisms is unknown at present. Furthermore, the 
presence of PMBN has been found'to reduce the frequency of 
conjugal gene transfer in E. coli (A. Matranga, P. Bennett & 
I. Chopra, personal communication). This finding could be the 
consequence of interference with cell to cell contact by PMBN. 
Therefore despite the disappointing observations made by Lam 
et al., 1986, PMBN may nevertheless prove to have future 
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